WO2018225543A1 - Compound and photocurable composition using same - Google Patents

Compound and photocurable composition using same Download PDF

Info

Publication number
WO2018225543A1
WO2018225543A1 PCT/JP2018/020225 JP2018020225W WO2018225543A1 WO 2018225543 A1 WO2018225543 A1 WO 2018225543A1 JP 2018020225 W JP2018020225 W JP 2018020225W WO 2018225543 A1 WO2018225543 A1 WO 2018225543A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
photocurable composition
compound
composition according
meth
Prior art date
Application number
PCT/JP2018/020225
Other languages
French (fr)
Japanese (ja)
Inventor
隆行 遠島
Original Assignee
日本化薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本化薬株式会社 filed Critical 日本化薬株式会社
Priority to JP2019523455A priority Critical patent/JPWO2018225543A1/en
Publication of WO2018225543A1 publication Critical patent/WO2018225543A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • C07D335/14Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16Oxygen atoms, e.g. thioxanthones
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00Compositions of epoxy resins; Compositions of derivatives of epoxy resins
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1339Gaskets; Spacers; Sealing of cells

Definitions

  • the present invention relates to a compound and a photocurable composition using the compound.
  • Photo-curable compositions are widely used in adhesive applications for electronic parts such as display sealants, solar cell sealants, and semiconductor sealants.
  • Examples of the display sealant include a liquid crystal display sealant, an organic EL display sealant, and a touch panel adhesive. These sealants for display are required to have excellent curability and low outgassing and do not damage the display element.
  • the photocurable composition does not undergo a curing reaction in a portion where light does not reach, there is a limit to the portion that can be used.
  • a light-shielding portion where light does not strike the liquid crystal sealing agent is generated due to the wiring portion of the array substrate of the liquid crystal display element and the black matrix portion of the color filter substrate.
  • a large amount of uncured components remain in the liquid crystal sealant.
  • the process proceeds to the secondary curing step by heat in this state, the dissolution of the uncured component in the liquid crystal is promoted by the heat, causing a display defect near the seal.
  • the present invention provides a compound that generates radicals by irradiation with light such as ultraviolet light and visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light, and a photocurable composition using the compound. For the purpose.
  • (meth) acryl means “acryl and / or methacryl”
  • (meth) acrylate means “acrylate and / or methacrylate”
  • (meth) acryloyl means “Means” acryloyl and / or methacryloyl ".
  • R 1 and R 2 are each independently a hydrogen atom, a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, (C1-C8 ) Represents an alkyl group or (C1-C8) alkoxy group, R 3 represents a (C1-C8) alkyl group or (C1-C8) alkoxy group, R 4 represents a hydrogen atom, (C1-C8) alkyl group, (C2-C8) represents an alkenyl group, an aryl group, or a heteroaryl group.
  • R 2 and R 3 may be bonded to each other to form a cyclic structure. Further, R 3 may be bonded to each other to form a dimer.
  • R 1 and R 2 are both hydrogen atoms.
  • R 4 is a methyl group.
  • the photocurable composition according to [5], wherein the curable compound is a (meth) acrylic compound.
  • thermosetting agent is an organic acid hydrazide compound.
  • the compound of the present invention generates radicals by irradiation with light such as ultraviolet light and visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light. For this reason, the photocurable composition using the compound of the present invention is used as a sealant used for manufacturing an electronic component having a light-shielding portion or an electronic component that needs to be cured by visible light, particularly as a sealant for a display. Useful.
  • R 1 and R 2 are each independently a hydrogen atom, carboxy group, sulfo group, hydroxy group, acetylamino group, halogen atom, cyano group, nitro group, sulfamoyl group, (C1-C8 ) Represents an alkyl group or (C1-C8) alkoxy group, R 3 represents a (C1-C8) alkyl group or (C1-C8) alkoxy group, R 4 represents a hydrogen atom, (C1-C8) alkyl group, (C2-C8) represents an alkenyl group, an aryl group, or a heteroaryl group.
  • R 2 and R 3 may be bonded to each other to form a cyclic structure. Further, R 3 may be bonded to each other to form a dimer.
  • R 1 and R 2 are substituted at any position of the thioxanthone skeleton.
  • Examples of the (C1-C8) alkyl group in R 1 and R 2 in the above formula (1) include a linear, branched, or cyclic unsubstituted group, and a linear one is preferable. Specific examples include linear groups such as methyl group, ethyl group, n-propyl group, n-butyl group, n-hentyl group, n-hexyl group, n-heptyl group, n-octyl group; isopropyl group Branched chain groups such as isobutyl group, sec-butyl group and tert-butyl group; cyclic groups such as cyclopropyl group, cyclopentyl group and cyclohexyl group;
  • the (C1-C8) alkyl group may be a group in which a chain alkyl group and a cyclic alkyl group are bonded, such as a 3-cyclopentylpropyl group. Among these, a
  • Examples of the (C1-C8) alkoxy group in R 1 and R 2 in the above formula (1) include a linear or branched unsubstituted group, and a linear group is preferable.
  • Specific examples include linear groups such as methoxy group, ethoxy group, n-propoxy group and n-butoxy group; branched chain groups such as isopropoxy group, isobutoxy group, sec-butoxy group and tert-butoxy group. And the like.
  • a methoxy group is preferable.
  • the (C1-C8) alkyl group or (C1-C8) alkoxy group in R 3 in the above formula (1), including preferred ones, includes the (C1-C8) alkyl group or (C1-C8) in R 1 and R 2 above.
  • C8) Represents the same meaning as the alkoxy group.
  • the (C1-C8) alkyl group in R 4 in the above formula (1) has the same meaning as the (C1-C8) alkyl group in R 1 and R 2 including the preferable one.
  • Examples of the (C2-C8) alkenyl group for R 4 in the above formula (1) include linear or branched unsubstituted groups. Specific examples include vinyl group, 1-propenyl group, 2-propenyl group and the like.
  • Examples of the aryl group and heteroaryl group in R 4 in the above formula (1) include a phenyl group, a pyridyl group, and a thienyl group.
  • the aryl group and heteroaryl group are substituted with at least one substituent such as a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, an alkyl group, and an alkoxy group. Also good.
  • substituent such as a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, an alkyl group, and an alkoxy group.
  • substituent such as a carboxy group, a sulfo
  • R 1 is a hydrogen atom or a (C1-C4) alkyl group
  • R 2 is a hydrogen atom or a (C1-C4) alkyl group
  • R 3 is a (C1-C8) alkyl group
  • R 4 is a methyl group, an aryl group, or a heteroaryl group.
  • R 1 and R 2 are preferably both hydrogen atoms.
  • R 4 is preferably a methyl group.
  • a more preferable combination of R 1 to R 4 in the above formula (1) includes a combination in which R 1 is a hydrogen atom, R 2 is a hydrogen atom, R 3 is a methyl group, and R 4 is a methyl group.
  • Specific examples of the compound according to this embodiment include, for example, the following compound numbers 1 to 20. However, it is not limited to these.
  • the compound of Compound No. 1 can be synthesized by the method described in Synthesis Example 2 of Example 1 described later, and the compound of Compound No. 1 is the compound of Example 1 described later. It can be synthesized by the method described in Synthesis Example 3.
  • the compound according to this embodiment generates radicals by irradiation with ultraviolet light or visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light. It also has good thermal stability, low volatility, good storage stability, and good solubility and is suitable for photopolymerization in the presence of air (oxygen). Therefore, the compound according to the present embodiment is useful as a photopolymerization initiator for polymerizing a curable compound capable of radical polymerization.
  • Photocurable composition [Compound represented by the above formula (1)]
  • the photocurable composition which concerns on this embodiment contains the compound represented by the said Formula (1).
  • the compound represented by the above formula (1) may be used alone or in combination of two or more.
  • the content of the compound represented by the above formula (1) is usually 0.001 to 10% by mass, preferably 0.002 to 5.0% by mass in the total amount of the photocurable composition. Preferably, the content is 0.1 to 3.0% by mass.
  • the content of the compound represented by the above formula (1) is 0.001% by mass or more, photopolymerization of the photocurable composition tends to proceed sufficiently.
  • an unreacted compound decreases that the content rate of the compound represented by the said Formula (1) is 10 mass% or less.
  • deterioration of light resistance and storage stability of the photocurable composition and adverse effects on display characteristics when the photocurable composition is used as a sealant for display elements tend to be suppressed.
  • the photocurable composition concerning this embodiment may contain other photoinitiators other than the compound denoted by the above-mentioned formula (1).
  • the other photopolymerization initiator is not particularly limited as long as it is a compound that generates a radical, an acid, a base, or the like by irradiation with ultraviolet light or visible light and initiates a chain polymerization reaction.
  • photopolymerization initiators include benzyl dimethyl ketal, 1-hydroxycyclohexyl phenyl ketone, diethyl thioxanthone, benzophenone, 2-ethylanthraquinone, 2-hydroxy-2-methylpropiophenone, 2-methyl- [ 4- (methylthio) phenyl] -2-morpholino-1-propane, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, camphorquinone, 9-fluorenone, diphenyl disulfide and the like.
  • Examples of the photopolymerization initiator having an absorbance at the maximum absorption wavelength ( ⁇ max) in the wavelength region of 200 to 300 nm of 500 or more include IRGACURE RTM 651, 184, and 2959. Examples of the photopolymerization initiator having an absorbance at the maximum absorption wavelength ( ⁇ max) in the wavelength region of 200 to 300 nm of 1500 or more include IRGACURE RTM 2959.
  • the photopolymerization initiator preferably has a molecular weight of 150 to 1000 from the viewpoint of preventing outgassing.
  • those having a (meth) acryl group in the molecule are preferable, for example, 2-methacryloyloxyethyl isocyanate and 1- [4- (2-hydroxyethoxy) -phenyl] -2-hydroxy
  • the reaction product with 2-methyl-1-propan-1-one is preferably used. This compound can be produced by the method described in International Publication No. 2006/027982.
  • the content is preferably 0.001 to 10% by mass in the total amount of the photocurable composition, More preferably, the content is 1 to 5.0% by mass.
  • the photocurable composition according to the present embodiment may contain a photoinitiation assistant such as a tertiary amine in order to further improve the curability.
  • a photoinitiation assistant such as a tertiary amine
  • the tertiary amines include, but are not limited to, ethyl p-dimethylaminobenzoate, isoamyl p-dimethylaminobenzoate, N, N-dimethylbenzylamine and the like.
  • a high molecular weight compound in which a plurality of tertiary amines are branched with a polyhydric alcohol or the like in one molecule can also be used as appropriate.
  • the content is preferably 0.005 to 20% by mass in the total amount of the photocurable composition, 0.01 More preferably, it is ⁇ 10% by mass.
  • the photocurable composition according to this embodiment preferably contains a curable compound.
  • a curable compound preferably contains a curable compound.
  • (meth) acrylic compounds such as a (meth) acrylic ester compound and an epoxy (meth) acrylate compound, are preferable.
  • a (meth) acryl compound may be used individually by 1 type, and may use 2 or more types together.
  • (meth) acrylic ester compounds include N-acryloyloxyethylhexahydrophthalimide, acryloylmorpholine, 2-hydroxypropyl (meth) acrylate, 4-hydroxybutyl (meth) acrylate, cyclohexane-1,4-dimethanol mono (Meth) acrylate, tetrahydrofurfuryl (meth) acrylate, phenoxyethyl (meth) acrylate, phenyl polyethoxy (meth) acrylate, 2-hydroxy-3-phenyloxypropyl (meth) acrylate, o-phenylphenol monoethoxy (meta ) Acrylate, o-phenylphenol polyethoxy (meth) acrylate, p-cumylphenoxyethyl (meth) acrylate, isobornyl (meth) acrylate, tribromo Enyloxyethyl (meth) acrylate, dicyclopentanyl
  • the epoxy (meth) acrylate compound can be obtained by a known method by reacting an epoxy compound with (meth) acrylic acid. Although it does not specifically limit as an epoxy compound used as a raw material, The epoxy compound more than bifunctional is preferable.
  • the bifunctional or higher functional epoxy compound include resorcin diglycidyl ether, bisphenol A type epoxy compound, bisphenol F type epoxy compound, bisphenol S type epoxy compound, phenol novolac type epoxy compound, cresol novolak type epoxy compound, bisphenol A novolak type Epoxy compounds, bisphenol F novolac type epoxy compounds, alicyclic epoxy compounds, aliphatic chain epoxy compounds, glycidyl ester type epoxy compounds, glycidyl amine type epoxy compounds, hydantoin type epoxy compounds, isocyanurate type epoxy compounds, triphenolmethane skeleton Phenol novolac-type epoxy compounds having di- and diglycidyl ethers of bifunctional phenols (catechol, resorcinol, etc.)
  • the photocurable composition according to the present embodiment when used as a liquid crystal sealant, bisphenol A type epoxy compounds and resorcin diglycidyl ether are preferable from the viewpoint of liquid crystal contamination.
  • the ratio of the epoxy group and the (meth) acryloyl group in the epoxy (meth) acrylate compound is not particularly limited, and is appropriately selected from the viewpoint of process compatibility.
  • the photocurable composition according to this embodiment preferably contains an epoxy compound (excluding the (meth) acrylic compound) in addition to the (meth) acrylic compound.
  • An epoxy compound may be used individually by 1 type, and may use 2 or more types together.
  • the epoxy compound is not particularly limited, but a bifunctional or higher functional epoxy compound is preferable.
  • the bifunctional or higher functional epoxy compound include resorcin diglycidyl ether, bisphenol A type epoxy resin, bisphenol F type epoxy resin, bisphenol S type epoxy resin, phenol novolac type epoxy resin, cresol novolac type epoxy resin, bisphenol A novolak type Epoxy resin, bisphenol F novolac type epoxy resin, alicyclic epoxy resin, aliphatic chain epoxy resin, glycidyl ester type epoxy resin, glycidyl amine type epoxy resin, hydantoin type epoxy resin, isocyanurate type epoxy resin, triphenolmethane skeleton Phenol novolac epoxy resin containing diglycidyl etherified products of bifunctional phenols (catechol, resorcinol, etc.), difunctional alcohols Glycidyl etherified product, and the like thereof halide or hydrogenated product.
  • the photocurable composition according to the present embodiment is
  • the content thereof is usually 10 to 80% by mass, preferably 20 to 70% by mass, based on the total amount of the photocurable composition. is there.
  • the photocurable composition according to this embodiment contains an epoxy compound, the content is usually 5 to 50% by mass, preferably 5 to 30% by mass, based on the total amount of the photocurable composition. It is.
  • the photocurable composition according to the present embodiment may contain an organic filler.
  • An organic filler may be used individually by 1 type, and may use 2 or more types together.
  • Examples of the organic filler include urethane fine particles, acrylic fine particles, styrene fine particles, styrene olefin fine particles, and silicone fine particles.
  • examples of the silicone fine particles include KMP-594, KMP-597, KMP-598 (manufactured by Shin-Etsu Chemical Co., Ltd.); Trefill RTM E-5500, 9701, EP-2001 (manufactured by Toray Dow Corning Co., Ltd.). preferable.
  • As urethane fine particles JB-800T and HB-800BK (manufactured by Negami Industrial Co., Ltd.) are preferable.
  • styrene fine particles Lavalon RTM T320C, T331C, SJ4400, SJ5400, SJ6400, SJ4300C, SJ5300C, and SJ6300C (manufactured by Mitsubishi Chemical Corporation) are preferable.
  • styrene olefin fine particles Septon RTM SEPS 2004 and SEPS 2063 (manufactured by Kuraray Co., Ltd.) are preferable.
  • These organic fillers may be core-shell organic fillers using two or more materials.
  • acrylic fine particles and silicone fine particles are preferable.
  • acrylic fine particles an acrylic rubber having a core-shell structure composed of two kinds of acrylic rubber is preferable, and the core layer is preferably n-butyl acrylate and the shell layer is more preferably methyl methacrylate.
  • Acrylic fine particles whose core layer is n-butyl acrylate and whose shell layer is methyl methacrylate are sold by Aika Kogyo Co., Ltd. as Zefiac RTM F-351.
  • Silicone fine particles include organopolysiloxane cross-linked powder, linear dimethylpolysiloxane cross-linked powder, and a composite silicone rubber in which a silicone resin (for example, polyorganosilsesquioxane resin) is coated on the surface of the silicone rubber.
  • a silicone resin for example, polyorganosilsesquioxane resin
  • Etc is a silicone rubber of a linear dimethylpolysiloxane crosslinked product powder, or a composite silicone rubber fine particle of a silicone resin-coated linear dimethylpolysiloxane crosslinked product powder.
  • the shape of the rubber powder is preferably a sphere with little increase in viscosity after addition.
  • the content is usually 5 to 50% by mass, preferably 5 to 40% by mass, based on the total amount of the photocurable composition. .
  • the photocurable composition according to this embodiment may contain an inorganic filler.
  • An inorganic filler may be used individually by 1 type, and may use 2 or more types together.
  • examples of the inorganic filler include silica, silicon carbide, silicon nitride, boron nitride, calcium carbonate, magnesium carbonate, barium sulfate, calcium sulfate, mica, talc, clay, alumina, magnesium oxide, zirconium oxide, aluminum hydroxide, and hydroxide.
  • Examples include magnesium, calcium silicate, aluminum silicate, lithium aluminum silicate, zirconium silicate, barium titanate, glass fiber, carbon fiber, molybdenum disulfide, asbestos, etc., preferably fused silica, crystalline silica, silicon nitride, boron nitride, carbonic acid
  • the particles include calcium, barium sulfate, calcium sulfate, mica, talc, clay, alumina, aluminum hydroxide, calcium silicate, and aluminum silicate, and particles such as silica, alumina, and talc are preferable.
  • the average particle size of the inorganic filler is suitably 2000 nm or less, preferably 1000 nm or less, more preferably 300 nm or less.
  • the average particle diameter of the inorganic filler is 2000 nm or less, for example, when producing a narrow gap liquid crystal cell using the photocurable composition according to the present embodiment as a liquid crystal sealing agent for a liquid crystal dropping method, the upper and lower There is a tendency that a gap can be formed well when a glass substrate is bonded.
  • a preferable minimum is about 10 nm, More preferably, it is about 100 nm.
  • the particle diameter can be measured with a laser diffraction / scattering particle size distribution analyzer (dry type) (manufactured by Seishin Enterprise Co., Ltd .; LMS-30).
  • the content of the photocurable composition according to the present embodiment contains an inorganic filler
  • the content is usually 5 to 50% by mass, preferably 5 to 40% by mass, based on the total amount of the photocurable composition. .
  • the adhesive strength to the glass substrate is improved and the moisture resistance reliability is also improved, so that a decrease in the adhesive strength after moisture absorption tends to be suppressed.
  • the content of the inorganic filler is 50% by mass or less, for example, when the liquid crystal cell is produced using the photocurable composition according to the present embodiment as a liquid crystal sealing agent for a liquid crystal dropping method, the inorganic filler is crushed. It tends to be easier and better.
  • the photocurable composition according to this embodiment may contain a silane coupling agent in order to improve adhesive strength and moisture resistance.
  • a silane coupling agent may be used individually by 1 type, and may use 2 or more types together.
  • silane coupling agents include 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, and 2- (3,4-epoxycyclohexyl).
  • Ethyltrimethoxysilane N-phenyl- ⁇ -aminopropyltrimethoxysilane, N- (2-aminoethyl) 3-aminopropylmethyldimethoxysilane, N- (2-aminoethyl) 3-aminopropylmethyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-mercaptopropyltrimethoxysilane, vinyltrimethoxysilane, N- (2- (vinylbenzylamino) ethyl) 3-aminopropyltrimethoxysilane hydrochloride, 3-methacryloxypropyltrimethoxy Silane 3-chloropropyl methyl dimethoxy silane, 3-chloropropyl trimethoxy silane, and the like. Since these silane coupling agents are sold by Shin-Etsu Chemical Co., Ltd. as KBM series, KBE series, etc., they are easily available from
  • the content is preferably 0.05 to 3% by mass in the total amount of the photocurable composition.
  • thermosetting agent The photocurable composition according to this embodiment may contain a thermosetting agent.
  • a thermosetting agent may be used individually by 1 type, and may use 2 or more types together.
  • thermosetting agent reacts nucleophilically with an unshared electron pair or an anion in the molecule, and examples thereof include polyvalent amines, polyhydric phenols, and organic acid hydrazide compounds. Among these, organic acid hydrazide compounds are preferably used.
  • examples of the aromatic hydrazide compound include terephthalic acid dihydrazide, isophthalic acid dihydrazide, 2,6-naphthoic acid dihydrazide, 2,6-pyridinedihydrazide, 1,2,4-benzenetrihydrazide, 1, Examples include 4,5,8-naphthoic acid tetrahydrazide and pyromellitic acid tetrahydrazide.
  • Examples of the aliphatic hydrazide compound among the organic acid hydrazide compounds include form hydrazide, acetohydrazide, propionic acid hydrazide, oxalic acid dihydrazide, malonic acid dihydrazide, succinic acid dihydrazide, glutaric acid dihydrazide, adipic acid dihydrazide, and pimelic acid dihydrazide.
  • organic acid hydrazide compounds isophthalic acid dihydrazide, malonic acid dihydrazide, adipic acid dihydrazide, tris (1-hydrazinocarbonylmethyl) isocyanurate, tris (1-hydrazinocarbonylethyl) are selected from the balance between curing reactivity and potential. ) Isocyanurate, tris (2-hydrazinocarbonylethyl) isocyanurate, and tris (3-hydrazinocarbonylpropyl) isocyanurate are preferred, and tris (2-hydrazinocarbonylethyl) isocyanurate is more preferred.
  • the content is usually 0.1 to 10% by mass, preferably 1 to 5% by mass, based on the total amount of the photocurable composition. %.
  • the photocurable composition according to this embodiment may contain a thermal radical polymerization initiator in order to improve the curing rate and curability.
  • a thermal radical polymerization initiator may be used individually by 1 type, and may use 2 or more types together.
  • the thermal radical polymerization initiator is not particularly limited as long as it is a compound that generates radicals by heating and initiates a chain polymerization reaction, such as organic peroxide, azo compound, benzoin compound, benzoin ether compound, acetophenone compound, benzopinacol, etc. And benzopinacol is preferably used.
  • organic peroxides include Kayamek RTM A, M, R, L, LH, SP-30C, Parkadox CH-50L, BC-FF, Cadox B-40ES, Parkadox 14, Trigonox RTM 22-70E. 23-C70, 121, 121-50E, 121-LS50E, 21-LS50E, 42, 42LS, Kayaester RTM P-70, TMPO-70, CND-C70, OO-50E, AN, Kayabutyl RTM B, Parkardox 16, Kayacaron RTM BIC-75, AIC-75 (above, manufactured by Kayaku Akzo Co., Ltd.); Permec RTM N, H, S, F, D, G, Perhexa RTM H, HC, TMH, C, V, 22, MC, Pakyua RTM AH, AL, HB, Perbutyl RTM H, C, ND, L , Pakumi RTM H, D, PEROYL RTM IB
  • examples of commercially available azo compounds include VA-044, 086, V-070, VPE-0201, VSP-1001 (above, manufactured by Wako Pure Chemical Industries, Ltd.) and the like.
  • the content thereof is usually 0.0001 to 10% by mass in the total amount of the photocurable composition, preferably 0.00. It is 0005 to 5% by mass, and more preferably 0.001 to 3% by mass.
  • the photocurable composition concerning this embodiment may contain additives, such as a hardening accelerator, a radical polymerization inhibitor, a pigment, a leveling agent, an antifoamer, and a solvent, as needed.
  • additives such as a hardening accelerator, a radical polymerization inhibitor, a pigment, a leveling agent, an antifoamer, and a solvent, as needed.
  • Examples of the curing accelerator include organic acids and imidazoles.
  • Examples of the organic acid include organic carboxylic acid and organic phosphoric acid, and organic carboxylic acid is preferable. Specifically, phthalic acid, isophthalic acid, terephthalic acid, trimellitic acid, benzophenone tetracarboxylic acid, furandicarboxylic acid, succinic acid, adipic acid, dodecanedioic acid, sebacic acid, thiodipropionic acid, cyclohexanedicarboxylic acid, tris (2-Carboxymethyl) isocyanurate, tris (2-carboxyethyl) isocyanurate, tris (2-carboxypropyl) isocyanurate, bis (2-carboxyethyl) isocyanurate and the like.
  • imidazole compounds examples include 2-methylimidazole, 2-phenylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-phenylimidazole, and 1-benzyl-2.
  • the content thereof is usually 0.1 to 10% by mass, preferably 1 to 5% by mass, based on the total amount of the photocurable composition. %.
  • the radical polymerization inhibitor is not particularly limited as long as it is a compound that prevents polymerization by reacting with radicals generated from a photo radical polymerization initiator or a thermal radical polymerization initiator, and is not limited to quinone, piperidine, hinders. Examples include radical polymerization inhibitors such as dophenol and nitroso.
  • naphthoquinone 2-hydroxynaphthoquinone, 2-methylnaphthoquinone, 2-methoxynaphthoquinone, 2,2,6,6-tetramethylpiperidine-1-oxyl, 2,2,6,6-tetramethyl-4 -Hydroxypiperidine-1-oxyl, 2,2,6,6, -tetramethyl-4-methoxypiperidine-1-oxyl, 2,2,6,6-tetramethyl-4-phenoxypiperidine-1-oxyl, hydroquinone 2-methylhydroquinone, 2-methoxyhydroquinone, parabenzoquinone, butylated hydroxyanisole, 2,6-di-t-butyl-4-ethylphenol, 2,6-di-t-butylcresol, stearyl ⁇ - (3 , 5-Di-tert-butyl-4-hydroxyphenyl) propionate, 2,2'-methylenebis 4-ethyl-6-tert-but
  • Adeka Adeka and the like.
  • naphthoquinone, hydroquinone, nitroso, and piperidine radical polymerization inhibitors are preferred, and naphthoquinone, 2-hydroxynaphthoquinone, hydroquinone, 2,6-di-tert-butyl-p-cresol, polystop 7300P ( Hakuto Co., Ltd.) is more preferable, and Polystop 7300P (Hakuto Co., Ltd.) is more preferable.
  • the content thereof is usually 0.0001 to 1% by mass, preferably 0.001 in the total amount of the photocurable composition. It is -0.5 mass%, More preferably, it is 0.01-0.2 mass%.
  • the viscosity at 25 ° C. of the photocurable composition according to this embodiment is preferably 150 to 500 Pa ⁇ s, more preferably 200 to 500 Pa ⁇ s.
  • the viscosity of the photocurable composition at 25 ° C. is preferably 250 to 400 Pa ⁇ s, and more preferably 280 to 320 Pa ⁇ s.
  • Examples of the method for preparing the photocurable composition according to this embodiment include the following methods. First, the compound represented by the formula (1) is heated and dissolved in the curable compound. Subsequently, after cooling to room temperature, an organic filler, an inorganic filler, a silane coupling agent, a thermosetting agent, a thermal radical polymerization initiator, an antifoaming agent, a leveling agent, a solvent, etc. are added as needed. And the photocurable composition which concerns on this embodiment can be prepared by mixing uniformly with well-known mixing apparatuses, such as a 3 roll, a sand mill, and a ball mill, and filtering with a metal mesh.
  • well-known mixing apparatuses such as a 3 roll, a sand mill, and a ball mill, and filtering with a metal mesh.
  • the photocurable composition according to the present embodiment is very useful as an electronic component sealant or an electronic component adhesive.
  • the electronic component sealant or the electronic component adhesive include, but are not limited to, flexible printed wiring board adhesives, TAB adhesives, semiconductor adhesives, various display adhesives, and the like. is not.
  • the photocurable composition according to this embodiment is very useful as an adhesive for liquid crystal display cells, particularly as a liquid crystal sealant.
  • An example is shown below about the liquid crystal display cell at the time of using the photocurable composition which concerns on this embodiment as a liquid-crystal sealing compound.
  • a liquid crystal display cell manufactured using an adhesive for a liquid crystal display cell has a pair of substrates each having a predetermined electrode formed on the substrate opposed to each other at a predetermined interval, and the periphery is sealed with a liquid crystal sealant, and a liquid crystal is interposed in the gap. Is enclosed.
  • the kind of liquid crystal to be sealed is not particularly limited.
  • the substrate is composed of a combination of substrates made of at least one of glass, quartz, plastic, silicone, etc. and having light transmission properties.
  • the manufacturing method of a liquid crystal display cell is as follows, for example.
  • a spacer (gap control material) is added to the liquid crystal sealant.
  • the spacer include glass fiber, silica beads, and polymer beads.
  • the diameter of the spacer varies depending on the purpose, but is usually 2 to 8 ⁇ m, preferably 4 to 7 ⁇ m.
  • the amount of use is usually 0.1 to 4 parts by mass, preferably 0.5 to 2 parts by mass, more preferably about 0.9 to 1.5 parts by mass with respect to 100 parts by mass of the liquid crystal sealant. It is.
  • the liquid crystal sealant is irradiated with ultraviolet rays by an ultraviolet irradiator and photocured.
  • the amount of ultraviolet irradiation is preferably 500 to 6000 mJ / cm 2 , more preferably 1000 to 4000 mJ / cm 2 . Thereafter, if necessary, it is cured at 90 to 130 ° C. for 1 to 2 hours to obtain a liquid crystal display cell.
  • the liquid crystal display cell thus obtained does not have a display defect due to liquid crystal contamination, and has excellent adhesion and moisture resistance reliability.
  • the photocurable composition according to the present embodiment is very suitable for use in an electronic component designed to have a light-shielding portion and an adhesive application that needs to be cured with low energy light such as visible light.
  • it is suitable as a liquid crystal display sealing agent, an organic EL sealing agent, and a touch panel adhesive used under a wiring light shielding portion.
  • thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min.
  • 2-Acetylthioxanthone (0.50 g), hydroxylamine hydrochloride (0.20 g), and N, N-dimethylformamide (60 mL) were added to the reaction vessel and reacted at 80 ° C. for 4 hours.
  • the reaction was stopped by adding 50 mL of water, extracted with methyl isobutyl ketone (200 mL), and washed with 50 mL of water three times.
  • the solvent was removed using an evaporator to obtain an oxime product of 2-acetylthioxanthone (TX-OX / yellow solid).
  • TX-OX / yellow solid The yellow solid (crude crystals) obtained here was used for the oxime esterification reaction as it was.
  • thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min.
  • a total amount of TX-OX, acetic anhydride (0.24 g), and butyl acetate (30 mL) were added to the reaction vessel, and the reaction was carried out at 90 ° C. for 5 hours.
  • the reaction was stopped by adding 50 mL of water, extracted with methyl isobutyl ketone (200 mL), and washed with 50 mL of water three times. The solvent was removed using an evaporator to obtain a yellow solid.
  • thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min.
  • TX-OX 0.5 g
  • benzoyl chloride 0.52 g
  • triethylamine 0.47 g
  • tetrahydrofuran 30 mL
  • Examples 2 and 3 The curable compounds (B-1, B-2, B-3) shown in Table 1 below were mixed and the photopolymerization initiator (A-1) shown in Table 1 below was heated and dissolved at 90 ° C. Until cooled. Next, the remaining components in Table 1 below were added and stirred, and then dispersed in a three-roll mill. Then, the photocurable composition of Example 2 and 3 was prepared by filtering with a metal mesh (635 mesh). In addition, the numerical value of each component in Table 1 represents a mass part.
  • the photocurable compositions of Examples 2 and 3 using TX-OXE as a photopolymerization initiator are the same as those of Comparative Examples 1 and 2 using a photopolymerization initiator having a similar structure.
  • the curability in the deep part (low energy irradiated part) was good in both ultraviolet and visible light. That is, it was confirmed that the photocurable compositions of Examples 2 and 3 have excellent curability at low energy.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Polymerisation Methods In General (AREA)
  • Sealing Material Composition (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

Provided is a compound represented by formula (1) and a photocurable composition using the compound. In formula (1): R1 and R2 each independently represent a hydrogen atom, a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, a (C1-C8) alkyl group, or a (C1-C8) alkoxy group; R3 represents a (C1-C8) alkyl group or a (C1-C8) alkoxy group; and R4 represents a hydrogen atom, a (C1-C8) alkyl group, a (C2-C8) alkenyl group, an aryl group, or a heteroaryl group. In formula (1), R2 and R3 may be bonded to each other and form a cyclic structure. In formula (1), R3 groups may also be bonded and form a dimer.

Description

化合物及びそれを用いた光硬化性組成物Compound and photocurable composition using the same
 本発明は、化合物及びそれを用いた光硬化性組成物に関する。 The present invention relates to a compound and a photocurable composition using the compound.
 光硬化性組成物は、ディスプレイ用封止剤、太陽電池用封止剤、半導体封止剤等の電子部品用接着剤用途で広く用いられている。ディスプレイ用封止剤としては、例えば、液晶ディスプレイ用シール剤、有機ELディスプレイ用封止剤、タッチパネル用接着剤等を挙げることができる。これらのディスプレイ用封止剤には、優れた硬化性を有しながら、アウトガスが少なく、表示素子にダメージを与えないという特性が要求される。 Photo-curable compositions are widely used in adhesive applications for electronic parts such as display sealants, solar cell sealants, and semiconductor sealants. Examples of the display sealant include a liquid crystal display sealant, an organic EL display sealant, and a touch panel adhesive. These sealants for display are required to have excellent curability and low outgassing and do not damage the display element.
 しかし、光硬化性組成物は、光の届かない部分で硬化反応が進行しないため、使用できる部分に制限がある。 However, since the photocurable composition does not undergo a curing reaction in a portion where light does not reach, there is a limit to the portion that can be used.
 特に、液晶滴下工法用液晶シール剤においては、液晶表示素子のアレイ基板の配線部分やカラーフィルター基板のブラックマトリクス部分により液晶シール剤に光が当たらない遮光部が生じ、シール近傍の表示不良の問題が以前よりも深刻なものとなっている。遮光部の存在によって光による一次硬化が不十分になると、液晶シール剤中に未硬化成分が多量に残存してしまう。この状態で熱による二次硬化工程に進んだ場合、当該未硬化成分の液晶への溶解が熱によって促進され、シール近傍の表示不良を引き起こすことになる。 In particular, in the liquid crystal sealing agent for the liquid crystal dropping method, a light-shielding portion where light does not strike the liquid crystal sealing agent is generated due to the wiring portion of the array substrate of the liquid crystal display element and the black matrix portion of the color filter substrate. Has become more serious than before. If the primary curing by light becomes insufficient due to the presence of the light shielding portion, a large amount of uncured components remain in the liquid crystal sealant. When the process proceeds to the secondary curing step by heat in this state, the dissolution of the uncured component in the liquid crystal is promoted by the heat, causing a display defect near the seal.
 このように、光が届き難く、非常に低エネルギーの光しか入らない箇所における感度を確保するためには、光重合開始剤の高感度化が非常に重要な課題である。 Thus, in order to secure the sensitivity in a place where light is difficult to reach and only light of very low energy enters, it is very important to increase the sensitivity of the photopolymerization initiator.
 この課題を解決するために、例えば、特許文献1のようなオキシムエステル型の光重合開始剤が開発されている。 In order to solve this problem, for example, an oxime ester type photopolymerization initiator as in Patent Document 1 has been developed.
特表2016-531926号公報JP-T-2016-53926
 本発明は、紫外光線や可視光線といった光照射によってラジカルを発生し、光に対する感度が高く、低エネルギー光によっても十分な反応性を示す化合物、及びそれを用いた光硬化性組成物を提供することを目的とする。 The present invention provides a compound that generates radicals by irradiation with light such as ultraviolet light and visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light, and a photocurable composition using the compound. For the purpose.
 本発明者らは、鋭意検討の結果、特定の構造を有する化合物が、非常に優れた反応性を有し、すなわち低エネルギーの光照射でも十分な反応性を有することを見出し、以下の[1]~[13]に記載の本発明を完成するに至った。
 なお、本明細書中、「(メタ)アクリル」とは「アクリル及び/又はメタクリル」を意味し、「(メタ)アクリレート」とは「アクリレート及び/又はメタクリレート」を意味し、「(メタ)アクリロイル」とは「アクリロイル及び/又はメタクリロイル」を意味する。
As a result of intensive studies, the present inventors have found that a compound having a specific structure has very excellent reactivity, that is, sufficient reactivity even when irradiated with light of low energy. The present invention described in [13] to [13] has been completed.
In the present specification, “(meth) acryl” means “acryl and / or methacryl”, “(meth) acrylate” means “acrylate and / or methacrylate”, and “(meth) acryloyl”. "Means" acryloyl and / or methacryloyl ".
[1] 下記式(1)で表される化合物。
Figure JPOXMLDOC01-appb-C000002
[式(1)中、R及びRはそれぞれ独立して、水素原子、カルボキシ基、スルホ基、ヒドロキシ基、アセチルアミノ基、ハロゲン原子、シアノ基、ニトロ基、スルファモイル基、(C1-C8)アルキル基、又は(C1-C8)アルコキシ基を表し、Rは(C1-C8)アルキル基又は(C1-C8)アルコキシ基を表し、Rは水素原子、(C1-C8)アルキル基、(C2-C8)アルケニル基、アリール基、又はヘテロアリール基を表す。RとRとが互いに結合して環状構造を形成していてもよい。また、R同士で結合して2量体を形成していてもよい。]
[2] 前記式(1)において、R及びRがいずれも水素原子である[1]に記載の化合物。
[3] 前記式(1)において、Rがメチル基である[1]又は[2]に記載の化合物。
[4] [1]~[3]のいずれか一項に記載の化合物を含有する光硬化性組成物。
[5] 硬化性化合物を含有する[4]に記載の光硬化性組成物。
[6] 前記硬化性化合物が(メタ)アクリル化合物である[5]に記載の光硬化性組成物。
[7] 前記硬化性化合物が、(メタ)アクリル化合物とエポキシ化合物との混合物である[5]に記載の光硬化性組成物。
[8] 有機フィラーを含有する[4]~[7]のいずれか一項に記載の光硬化性組成物。
[9] 前記有機フィラーが、ウレタン微粒子、アクリル微粒子、スチレン微粒子、スチレンオレフィン微粒子、及びシリコーン微粒子からなる群より選択される少なくとも1種の有機フィラーである[8]に記載の光硬化性組成物。
[10] 無機フィラーを含有する[4]~[9]のいずれか一項に記載の光硬化性組成物。
[11] シランカップリング剤を含有する[4]~[10]のいずれか一項に記載の光硬化性組成物。
[12] 熱硬化剤を含有する[4]~[11]のいずれか一項に記載の光硬化性組成物。
[13] 前記熱硬化剤が有機酸ヒドラジド化合物である[12]に記載の光硬化性組成物。
[1] A compound represented by the following formula (1).
Figure JPOXMLDOC01-appb-C000002
[In Formula (1), R 1 and R 2 are each independently a hydrogen atom, a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, (C1-C8 ) Represents an alkyl group or (C1-C8) alkoxy group, R 3 represents a (C1-C8) alkyl group or (C1-C8) alkoxy group, R 4 represents a hydrogen atom, (C1-C8) alkyl group, (C2-C8) represents an alkenyl group, an aryl group, or a heteroaryl group. R 2 and R 3 may be bonded to each other to form a cyclic structure. Further, R 3 may be bonded to each other to form a dimer. ]
[2] The compound according to [1], wherein in formula (1), R 1 and R 2 are both hydrogen atoms.
[3] The compound according to [1] or [2], wherein in the formula (1), R 4 is a methyl group.
[4] A photocurable composition containing the compound according to any one of [1] to [3].
[5] The photocurable composition according to [4], which contains a curable compound.
[6] The photocurable composition according to [5], wherein the curable compound is a (meth) acrylic compound.
[7] The photocurable composition according to [5], wherein the curable compound is a mixture of a (meth) acrylic compound and an epoxy compound.
[8] The photocurable composition according to any one of [4] to [7], which contains an organic filler.
[9] The photocurable composition according to [8], wherein the organic filler is at least one organic filler selected from the group consisting of urethane fine particles, acrylic fine particles, styrene fine particles, styrene olefin fine particles, and silicone fine particles. .
[10] The photocurable composition according to any one of [4] to [9], which contains an inorganic filler.
[11] The photocurable composition according to any one of [4] to [10], which contains a silane coupling agent.
[12] The photocurable composition according to any one of [4] to [11], which contains a thermosetting agent.
[13] The photocurable composition according to [12], wherein the thermosetting agent is an organic acid hydrazide compound.
 本発明の化合物は、紫外光線や可視光線といった光照射によってラジカルを発生させるものであり、光に対する感度が高く、低エネルギー光によっても十分な反応性を示す。このため、本発明の化合物を用いた光硬化性組成物は、遮光部分を有する電子部品や可視光によって硬化させる必要のある電子部品の製造に用いられる封止剤、特にディスプレイ用封止剤として有用である。 The compound of the present invention generates radicals by irradiation with light such as ultraviolet light and visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light. For this reason, the photocurable composition using the compound of the present invention is used as a sealant used for manufacturing an electronic component having a light-shielding portion or an electronic component that needs to be cured by visible light, particularly as a sealant for a display. Useful.
<化合物>
 本実施形態に係る化合物は、下記式(1)で表される構造を有する。
<Compound>
The compound according to this embodiment has a structure represented by the following formula (1).
Figure JPOXMLDOC01-appb-C000003
Figure JPOXMLDOC01-appb-C000003
 上記式(1)中、R及びRはそれぞれ独立して、水素原子、カルボキシ基、スルホ基、ヒドロキシ基、アセチルアミノ基、ハロゲン原子、シアノ基、ニトロ基、スルファモイル基、(C1-C8)アルキル基、又は(C1-C8)アルコキシ基を表し、Rは(C1-C8)アルキル基又は(C1-C8)アルコキシ基を表し、Rは水素原子、(C1-C8)アルキル基、(C2-C8)アルケニル基、アリール基、又はヘテロアリール基を表す。RとRとが互いに結合して環状構造を形成していてもよい。また、R同士で結合して2量体を形成していてもよい。 In the above formula (1), R 1 and R 2 are each independently a hydrogen atom, carboxy group, sulfo group, hydroxy group, acetylamino group, halogen atom, cyano group, nitro group, sulfamoyl group, (C1-C8 ) Represents an alkyl group or (C1-C8) alkoxy group, R 3 represents a (C1-C8) alkyl group or (C1-C8) alkoxy group, R 4 represents a hydrogen atom, (C1-C8) alkyl group, (C2-C8) represents an alkenyl group, an aryl group, or a heteroaryl group. R 2 and R 3 may be bonded to each other to form a cyclic structure. Further, R 3 may be bonded to each other to form a dimer.
 なお、R及びRは、チオキサントン骨格の任意の位置に置換するものである。 R 1 and R 2 are substituted at any position of the thioxanthone skeleton.
 上記式(1)中のR及びRにおける(C1-C8)アルキル基としては、直鎖状、分岐鎖状、又は環状の非置換のものが挙げられ、直鎖状のものが好ましい。具体例としては、メチル基、エチル基、n-プロピル基、n-ブチル基、n-ヘンチル基、n-ヘキシル基、n-ヘプチル基、n-オクチル基等の直鎖状のもの;イソプロピル基、イソブチル基、sec-ブチル基、tert-ブチル基等の分岐鎖状のもの;シクロプロピル基、シクロペンチル基、シクロヘキシル基等の環状のもの;などが挙げられる。(C1-C8)アルキル基は、3-シクロペンチルプロピル基等のように、鎖状のアルキル基と環状のアルキル基とが結合したものであってもよい。これらの中でも、メチル基及びn-プロピル基が好ましく、メチル基がより好ましい。 Examples of the (C1-C8) alkyl group in R 1 and R 2 in the above formula (1) include a linear, branched, or cyclic unsubstituted group, and a linear one is preferable. Specific examples include linear groups such as methyl group, ethyl group, n-propyl group, n-butyl group, n-hentyl group, n-hexyl group, n-heptyl group, n-octyl group; isopropyl group Branched chain groups such as isobutyl group, sec-butyl group and tert-butyl group; cyclic groups such as cyclopropyl group, cyclopentyl group and cyclohexyl group; The (C1-C8) alkyl group may be a group in which a chain alkyl group and a cyclic alkyl group are bonded, such as a 3-cyclopentylpropyl group. Among these, a methyl group and an n-propyl group are preferable, and a methyl group is more preferable.
 上記式(1)中のR及びRにおける(C1-C8)アルコキシ基としては、直鎖状又は分岐鎖状の非置換のものが挙げられ、直鎖状のものが好ましい。具体例としては、メトキシ基、エトキシ基、n-プロポキシ基、n-ブトキシ基等の直鎖状のもの;イソプロポキシ基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ基等の分岐鎖状のもの;などが挙げられる。これらの中でも、メトキシ基が好ましい。 Examples of the (C1-C8) alkoxy group in R 1 and R 2 in the above formula (1) include a linear or branched unsubstituted group, and a linear group is preferable. Specific examples include linear groups such as methoxy group, ethoxy group, n-propoxy group and n-butoxy group; branched chain groups such as isopropoxy group, isobutoxy group, sec-butoxy group and tert-butoxy group. And the like. Among these, a methoxy group is preferable.
 上記式(1)中のRにおける(C1-C8)アルキル基又は(C1-C8)アルコキシ基は、好ましいものを含め、上記R及びRにおける(C1-C8)アルキル基又は(C1-C8)アルコキシ基と同じ意味を表す。 The (C1-C8) alkyl group or (C1-C8) alkoxy group in R 3 in the above formula (1), including preferred ones, includes the (C1-C8) alkyl group or (C1-C8) in R 1 and R 2 above. C8) Represents the same meaning as the alkoxy group.
 上記式(1)中のRにおける(C1-C8)アルキル基は、好ましいものを含め、上記R及びRにおける(C1-C8)アルキル基と同じ意味を表す。 The (C1-C8) alkyl group in R 4 in the above formula (1) has the same meaning as the (C1-C8) alkyl group in R 1 and R 2 including the preferable one.
 上記式(1)中のRにおける(C2-C8)アルケニル基としては、直鎖状又は分岐鎖状の非置換のものが挙げられる。具体例としては、ビニル基、1-プロペニル基、2-プロペニル基等が挙げられる。 Examples of the (C2-C8) alkenyl group for R 4 in the above formula (1) include linear or branched unsubstituted groups. Specific examples include vinyl group, 1-propenyl group, 2-propenyl group and the like.
 上記式(1)中のRにおけるアリール基及びヘテロアリール基としては、フェニル基、ピリジル基、チエニル基等が挙げられる。アリール基及びヘテロアリール基は、カルボキシ基、スルホ基、ヒドロキシ基、アセチルアミノ基、ハロゲン原子、シアノ基、ニトロ基、スルファモイル基、アルキル基、アルコキシ基等の少なくとも1つの置換基で置換されていてもよい。このような置換基を有するものとしては、例えば、4-ニトロフェニル基が挙げられる。 Examples of the aryl group and heteroaryl group in R 4 in the above formula (1) include a phenyl group, a pyridyl group, and a thienyl group. The aryl group and heteroaryl group are substituted with at least one substituent such as a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, an alkyl group, and an alkoxy group. Also good. Examples of those having such a substituent include a 4-nitrophenyl group.
 上記式(1)中のR~Rにおける好ましい組み合わせとしては、Rが水素原子又は(C1-C4)アルキル基であり、Rが水素原子又は(C1-C4)アルキル基であり、Rが(C1-C8)アルキル基であり、Rがメチル基、アリール基、又はヘテロアリール基である組み合わせが挙げられる。R及びRは、いずれも水素原子であることが好ましい。また、Rは、メチル基であることが好ましい。上記式(1)中のR~Rにおけるより好ましい組み合わせとしては、Rが水素原子、Rが水素原子、Rがメチル基、Rがメチル基である組み合わせが挙げられる。 As a preferable combination of R 1 to R 4 in the above formula (1), R 1 is a hydrogen atom or a (C1-C4) alkyl group, R 2 is a hydrogen atom or a (C1-C4) alkyl group, And a combination in which R 3 is a (C1-C8) alkyl group and R 4 is a methyl group, an aryl group, or a heteroaryl group. R 1 and R 2 are preferably both hydrogen atoms. R 4 is preferably a methyl group. A more preferable combination of R 1 to R 4 in the above formula (1) includes a combination in which R 1 is a hydrogen atom, R 2 is a hydrogen atom, R 3 is a methyl group, and R 4 is a methyl group.
 本実施形態に係る化合物の具体例としては、例えば、以下の化合物番号1~20の化合物が挙げられる。ただし、これらに限定されるものではない。 Specific examples of the compound according to this embodiment include, for example, the following compound numbers 1 to 20. However, it is not limited to these.
Figure JPOXMLDOC01-appb-C000004
Figure JPOXMLDOC01-appb-C000004
 本実施形態に係る化合物のうち、例えば化合物番号1の化合物は、後述する実施例1の合成例2に記載の方法で合成することができ、化合物番号1の化合物は、後述する実施例1の合成例3に記載の方法で合成することができる。 Among the compounds according to this embodiment, for example, the compound of Compound No. 1 can be synthesized by the method described in Synthesis Example 2 of Example 1 described later, and the compound of Compound No. 1 is the compound of Example 1 described later. It can be synthesized by the method described in Synthesis Example 3.
 本実施形態に係る化合物は、紫外光線や可視光線の照射によってラジカルを発生させるものであり、光に対する感度が高く、低エネルギー光によっても十分な反応性を示す。また、良好な熱安定性、低い揮発性、良好な貯蔵安定性、及び良好な溶解性を有し、空気(酸素)の存在下での光重合にも適している。したがって、本実施形態に係る化合物は、ラジカル重合可能な硬化性化合物を重合させる光重合開始剤として有用である。 The compound according to this embodiment generates radicals by irradiation with ultraviolet light or visible light, has high sensitivity to light, and exhibits sufficient reactivity even with low energy light. It also has good thermal stability, low volatility, good storage stability, and good solubility and is suitable for photopolymerization in the presence of air (oxygen). Therefore, the compound according to the present embodiment is useful as a photopolymerization initiator for polymerizing a curable compound capable of radical polymerization.
<光硬化性組成物>
[上記式(1)で表される化合物]
 本実施形態に係る光硬化性組成物は、上記式(1)で表される化合物を含有する。上記式(1)で表される化合物は、1種を単独で使用してもよく、2種以上を併用してもよい。
<Photocurable composition>
[Compound represented by the above formula (1)]
The photocurable composition which concerns on this embodiment contains the compound represented by the said Formula (1). The compound represented by the above formula (1) may be used alone or in combination of two or more.
 上記式(1)で表される化合物の含有率は、光硬化性組成物の総量中、通常0.001~10質量%であり、好ましくは0.002~5.0質量%であり、より好ましくは0.1~3.0質量%である。上記式(1)で表される化合物の含有率が0.001質量%以上であると、光硬化性組成物の光重合が十分に進行する傾向にある。一方、上記式(1)で表される化合物の含有率が10質量%以下であると、未反応の化合物が少なくなる。その結果、光硬化性組成物の耐光性及び保存安定性の悪化や、光硬化性組成物を表示素子用封止剤として用いた場合における表示特性への悪影響が抑えられる傾向にある。 The content of the compound represented by the above formula (1) is usually 0.001 to 10% by mass, preferably 0.002 to 5.0% by mass in the total amount of the photocurable composition. Preferably, the content is 0.1 to 3.0% by mass. When the content of the compound represented by the above formula (1) is 0.001% by mass or more, photopolymerization of the photocurable composition tends to proceed sufficiently. On the other hand, an unreacted compound decreases that the content rate of the compound represented by the said Formula (1) is 10 mass% or less. As a result, deterioration of light resistance and storage stability of the photocurable composition and adverse effects on display characteristics when the photocurable composition is used as a sealant for display elements tend to be suppressed.
[光重合開始剤]
 本実施形態に係る光硬化性組成物は、上記式(1)で表される化合物以外に、他の光重合開始剤を含有していてもよい。他の光重合開始剤としては、紫外光線や可視光線の照射によってラジカル、酸、塩基等を発生し、連鎖重合反応を開始させる化合物であれば特に限定されない。
[Photopolymerization initiator]
The photocurable composition concerning this embodiment may contain other photoinitiators other than the compound denoted by the above-mentioned formula (1). The other photopolymerization initiator is not particularly limited as long as it is a compound that generates a radical, an acid, a base, or the like by irradiation with ultraviolet light or visible light and initiates a chain polymerization reaction.
 他の光重合開始剤の具体例としては、ベンジルジメチルケタール、1-ヒドロキシシクロヘキシルフェニルケトン、ジエチルチオキサントン、ベンゾフェノン、2-エチルアンスラキノン、2-ヒドロキシ-2-メチルプロピオフェノン、2-メチル-〔4-(メチルチオ)フェニル〕-2-モルフォリノ-1-プロパン、2,4,6-トリメチルベンゾイルジフェニルホスフィンオキサイド、カンファーキノン、9-フルオレノン、ジフェニルジスルフィド等が挙げられる。市販品としては、IRGACURERTM 651、184、2959、127、907、396、379EG、819、784、754、500、OXE01、OXE02、DAROCURERTM 1173、LUCIRINRTM TPO(以上、BASF社製);セイクオールRTMZ、BZ、BEE、BIP、BBI(以上、精工化学株式会社製);等が挙げられる。なお、本明細書において上付きの「RTM」は登録商標を意味する。 Specific examples of other photopolymerization initiators include benzyl dimethyl ketal, 1-hydroxycyclohexyl phenyl ketone, diethyl thioxanthone, benzophenone, 2-ethylanthraquinone, 2-hydroxy-2-methylpropiophenone, 2-methyl- [ 4- (methylthio) phenyl] -2-morpholino-1-propane, 2,4,6-trimethylbenzoyldiphenylphosphine oxide, camphorquinone, 9-fluorenone, diphenyl disulfide and the like. Examples of commercially available products, IRGACURE RTM 651,184,2959,127,907,396,379EG, 819,784,754,500, OXE01 , OXE02, DAROCURE RTM 1173, LUCIRIN RTM TPO ( manufactured by BASF); Seikuoru RTM Z, BZ, BEE, BIP, BBI (manufactured by Seiko Chemical Co., Ltd.); In the present specification, the superscript “RTM” means a registered trademark.
 これらの中でも、幅広い波長の光吸収を利用し、光硬化性組成物の硬化性を高める観点から、200~300nmの波長領域における極大吸収波長(λmax)の吸光度が400以上である光重合開始剤が好ましく、200~300nmの波長領域における極大吸収波長(λmax)の吸光度が500以上である光重合開始剤がより好ましく、200~300nmの波長領域における極大吸収波長(λmax)の吸光度が1500以上である光重合開始剤がさらに好ましい。200~300nmの波長領域における極大吸収波長(λmax)の吸光度が500以上である光重合開始剤としては、例えば、IRGACURERTM 651、184、2959が挙げられる。また、200~300nmの波長領域における極大吸収波長(λmax)の吸光度が1500以上である光重合開始剤としては、例えば、IRGACURERTM 2959が挙げられる。 Among these, a photopolymerization initiator having a maximum absorption wavelength (λmax) absorbance of 400 or more in a wavelength region of 200 to 300 nm from the viewpoint of enhancing light curability of a photocurable composition by utilizing light absorption in a wide range of wavelengths. More preferable is a photopolymerization initiator having an absorbance at a maximum absorption wavelength (λmax) in the wavelength region of 200 to 300 nm of 500 or more, and an absorbance at a maximum absorption wavelength (λmax) in the wavelength region of 200 to 300 nm is more than 1500. Some photoinitiators are more preferred. Examples of the photopolymerization initiator having an absorbance at the maximum absorption wavelength (λmax) in the wavelength region of 200 to 300 nm of 500 or more include IRGACURE RTM 651, 184, and 2959. Examples of the photopolymerization initiator having an absorbance at the maximum absorption wavelength (λmax) in the wavelength region of 200 to 300 nm of 1500 or more include IRGACURE RTM 2959.
 また、光重合開始剤としては、アウトガス防止の観点から、分子量150~1000のものが好ましい。同様に、アウトガス防止の観点から、分子内に(メタ)アクリル基を有するものが好ましく、例えば、2-メタクリロイルオキシエチルイソシアネートと1-[4-(2-ヒドロキシエトキシ)-フェニル]-2-ヒドロキシ-2メチル-1-プロパン-1-オンとの反応生成物が好適に用いられる。この化合物は、国際公開第2006/027982号記載の方法にて製造することができる。 The photopolymerization initiator preferably has a molecular weight of 150 to 1000 from the viewpoint of preventing outgassing. Similarly, from the viewpoint of preventing outgassing, those having a (meth) acryl group in the molecule are preferable, for example, 2-methacryloyloxyethyl isocyanate and 1- [4- (2-hydroxyethoxy) -phenyl] -2-hydroxy The reaction product with 2-methyl-1-propan-1-one is preferably used. This compound can be produced by the method described in International Publication No. 2006/027982.
 本実施形態に係る光硬化性組成物が他の光重合開始剤を含有する場合、その含有率は、光硬化性組成物の総量中、0.001~10質量%であることが好ましく、0.1~5.0質量%であることがより好ましい。 When the photocurable composition according to this embodiment contains other photopolymerization initiator, the content is preferably 0.001 to 10% by mass in the total amount of the photocurable composition, More preferably, the content is 1 to 5.0% by mass.
[光開始助剤]
 本実施形態に係る光硬化性組成物は、硬化性をさらに高めるため、三級アミン類等の光開始助剤を含有していてもよい。三級アミン類としては、特に限定されないが、p-ジメチルアミノ安息香酸エチル、p-ジメチルアミノ安息香酸イソアミル、N,N-ジメチルベンジルアミン等が挙げられる。また、一分子内に複数の三級アミン類を多価アルコール等で分岐させた高分子量化合物も適宜使用することができる。
[Photoinitiator]
The photocurable composition according to the present embodiment may contain a photoinitiation assistant such as a tertiary amine in order to further improve the curability. The tertiary amines include, but are not limited to, ethyl p-dimethylaminobenzoate, isoamyl p-dimethylaminobenzoate, N, N-dimethylbenzylamine and the like. Moreover, a high molecular weight compound in which a plurality of tertiary amines are branched with a polyhydric alcohol or the like in one molecule can also be used as appropriate.
 本実施形態に係る光硬化性組成物が光開始助剤を含有する場合、その含有率は、光硬化性組成物の総量中、0.005~20質量%であることが好ましく、0.01~10質量%であることがより好ましい。 When the photocurable composition according to this embodiment contains a photoinitiator auxiliary, the content is preferably 0.005 to 20% by mass in the total amount of the photocurable composition, 0.01 More preferably, it is ˜10% by mass.
[硬化性化合物]
 本実施形態に係る光硬化性組成物は、硬化性化合物を含有することが好ましい。硬化性化合物としては、光、熱等によって硬化する化合物であれば特に限定されないが、(メタ)アクリルエステル化合物、エポキシ(メタ)アクリレート化合物等の(メタ)アクリル化合物が好ましい。(メタ)アクリル化合物は、1種を単独で使用してもよく、2種以上を併用してもよい。
[Curable compound]
The photocurable composition according to this embodiment preferably contains a curable compound. Although it will not specifically limit as a sclerosing | hardenable compound if it is a compound hardened | cured by light, heat | fever, etc., (meth) acrylic compounds, such as a (meth) acrylic ester compound and an epoxy (meth) acrylate compound, are preferable. A (meth) acryl compound may be used individually by 1 type, and may use 2 or more types together.
 (メタ)アクリルエステル化合物としては、例えば、N-アクリロイルオキシエチルヘキサヒドロフタルイミド、アクリロイルモルホリン、2-ヒドロキシプロピル(メタ)アクリレート、4-ヒドロキシブチル(メタ)アクリレート、シクロヘキサン-1,4-ジメタノールモノ(メタ)アクリレート、テトラヒドロフロフリル(メタ)アクリレート、フェノキシエチル(メタ)アクリレート、フェニルポリエトキシ(メタ)アクリレート、2-ヒドロキシ-3-フェニルオキシプロピル(メタ)アクリレート、o-フェニルフェノールモノエトキシ(メタ)アクリレート、o-フェニルフェノールポリエトキシ(メタ)アクリレート、p-クミルフェノキシエチル(メタ)アクリレート、イソボニル(メタ)アクリレート、トリブロモフェニルオキシエチル(メタ)アクリレート、ジシクロペンタニル(メタ)アクリレート、ジシクロペンテニル(メタ)アクリレート、ジシクロペンテニルオキシエチル(メタ)アクリレート、1,4-ブタンジオールジ(メタ)アクリレート、1,6-ヘキサンジオールジ(メタ)アクリレート、1,9-ノナンジオールジ(メタ)アクリレート、トリシクロデカンジメタノール(メタ)アクリレート、ビスフェノールAポリエトキシジ(メタ)アクリレート、ビスフェノールAポリプロポキシジ(メタ)アクリレート、ビスフェノールFポリエトキシジ(メタ)アクリレート、エチレングリコールジ(メタ)アクリレート、ポリエチレングリコールジ(メタ)アクリレート、トリス((メタ)アクリロキシエチル)イソシアヌレート、ペンタエリスリトールテトラ(メタ)アクリレート、ジペンタエリスリトールヘキサ(メタ)アクリレート、ジペンタエリスリトールペンタ(メタ)アクリレート、トリペンタエリスリトールヘキサ(メタ)アクリレート、トリペンタエリスリトールペンタ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート、トリメチロールプロパンポリエトキシトリ(メタ)アクリレート、ジトリメチロールプロパンテトラ(メタ)アクリレート、ネオペンチルグリコールとヒドロキシピバリン酸とのエステルジアクリレート、ネオペンチルグリコールとヒドロキシピバリン酸とのエステルのε-カプロラクトン付加物のジアクリレート等が挙げられる。これらの中でも、N-アクリロイルオキシエチルヘキサヒドロフタルイミド、フェノキシエチル(メタ)アクリレート、及びジシクロペンテニルオキシエチル(メタ)アクリレートが好ましい。 Examples of (meth) acrylic ester compounds include N-acryloyloxyethylhexahydrophthalimide, acryloylmorpholine, 2-hydroxypropyl (meth) acrylate, 4-hydroxybutyl (meth) acrylate, cyclohexane-1,4-dimethanol mono (Meth) acrylate, tetrahydrofurfuryl (meth) acrylate, phenoxyethyl (meth) acrylate, phenyl polyethoxy (meth) acrylate, 2-hydroxy-3-phenyloxypropyl (meth) acrylate, o-phenylphenol monoethoxy (meta ) Acrylate, o-phenylphenol polyethoxy (meth) acrylate, p-cumylphenoxyethyl (meth) acrylate, isobornyl (meth) acrylate, tribromo Enyloxyethyl (meth) acrylate, dicyclopentanyl (meth) acrylate, dicyclopentenyl (meth) acrylate, dicyclopentenyloxyethyl (meth) acrylate, 1,4-butanediol di (meth) acrylate, 1,6 -Hexanediol di (meth) acrylate, 1,9-nonanediol di (meth) acrylate, tricyclodecane dimethanol (meth) acrylate, bisphenol A polyethoxydi (meth) acrylate, bisphenol A polypropoxy di (meth) acrylate, bisphenol F polyethoxydi (meth) acrylate, ethylene glycol di (meth) acrylate, polyethylene glycol di (meth) acrylate, tris ((meth) acryloxyethyl) isocyanurate, pe Taerythritol tetra (meth) acrylate, dipentaerythritol hexa (meth) acrylate, dipentaerythritol penta (meth) acrylate, tripentaerythritol hexa (meth) acrylate, tripentaerythritol penta (meth) acrylate, trimethylolpropane tri (meta) ) Acrylate, trimethylolpropane polyethoxytri (meth) acrylate, ditrimethylolpropane tetra (meth) acrylate, ester diacrylate of neopentyl glycol and hydroxypivalic acid, ε-caprolactone of ester of neopentyl glycol and hydroxypivalic acid Examples thereof include diacrylates of adducts. Among these, N-acryloyloxyethyl hexahydrophthalimide, phenoxyethyl (meth) acrylate, and dicyclopentenyloxyethyl (meth) acrylate are preferable.
 エポキシ(メタ)アクリレート化合物は、エポキシ化合物と(メタ)アクリル酸との反応により公知の方法で得られる。原料となるエポキシ化合物としては、特に限定されるものではないが、2官能以上のエポキシ化合物が好ましい。2官能以上のエポキシ化合物としては、例えば、レゾルシンジグリシジルエーテル、ビスフェノールA型エポキシ化合物、ビスフェノールF型エポキシ化合物、ビスフェノールS型エポキシ化合物、フェノールノボラック型エポキシ化合物、クレゾールノボラック型エポキシ化合物、ビスフェノールAノボラック型エポキシ化合物、ビスフェノールFノボラック型エポキシ化合物、脂環式エポキシ化合物、脂肪族鎖状エポキシ化合物、グリシジルエステル型エポキシ化合物、グリシジルアミン型エポキシ化合物、ヒダントイン型エポキシ化合物、イソシアヌレート型エポキシ化合物、トリフェノールメタン骨格を有するフェノールノボラック型エポキシ化合物、二官能フェノール類(カテコール、レゾルシノール等)のジグリシジルエーテル化物、二官能アルコール類のジグリシジルエーテル化物、及びそれらのハロゲン化物又は水素添加物などが挙げられる。これらの中でも、本実施形態に係る光硬化性組成物を液晶シール剤として用いる場合には、液晶汚染性の観点から、ビスフェノールA型エポキシ化合物及びレゾルシンジグリシジルエーテルが好ましい。エポキシ(メタ)アクリレート化合物におけるエポキシ基と(メタ)アクリロイル基との比率は特に限定されず、工程適合性の観点から適切に選択される。 The epoxy (meth) acrylate compound can be obtained by a known method by reacting an epoxy compound with (meth) acrylic acid. Although it does not specifically limit as an epoxy compound used as a raw material, The epoxy compound more than bifunctional is preferable. Examples of the bifunctional or higher functional epoxy compound include resorcin diglycidyl ether, bisphenol A type epoxy compound, bisphenol F type epoxy compound, bisphenol S type epoxy compound, phenol novolac type epoxy compound, cresol novolak type epoxy compound, bisphenol A novolak type Epoxy compounds, bisphenol F novolac type epoxy compounds, alicyclic epoxy compounds, aliphatic chain epoxy compounds, glycidyl ester type epoxy compounds, glycidyl amine type epoxy compounds, hydantoin type epoxy compounds, isocyanurate type epoxy compounds, triphenolmethane skeleton Phenol novolac-type epoxy compounds having di- and diglycidyl ethers of bifunctional phenols (catechol, resorcinol, etc.) Things, difunctional alcohols diglycidyl ethers of, and the like thereof halide or hydrogenated product. Among these, when the photocurable composition according to the present embodiment is used as a liquid crystal sealant, bisphenol A type epoxy compounds and resorcin diglycidyl ether are preferable from the viewpoint of liquid crystal contamination. The ratio of the epoxy group and the (meth) acryloyl group in the epoxy (meth) acrylate compound is not particularly limited, and is appropriately selected from the viewpoint of process compatibility.
 本実施形態に係る光硬化性組成物は、(メタ)アクリル化合物に加えて、エポキシ化合物(ただし、(メタ)アクリル化合物を除く)を含有することが好ましい。エポキシ化合物は、1種を単独で使用してもよく、2種以上を併用してもよい。 The photocurable composition according to this embodiment preferably contains an epoxy compound (excluding the (meth) acrylic compound) in addition to the (meth) acrylic compound. An epoxy compound may be used individually by 1 type, and may use 2 or more types together.
 エポキシ化合物としては、特に限定されるものではないが、2官能以上のエポキシ化合物が好ましい。2官能以上のエポキシ化合物としては、例えば、レゾルシンジグリシジルエーテル、ビスフェノールA型エポキシ樹脂、ビスフェノールF型エポキシ樹脂、ビスフェノールS型エポキシ樹脂、フェノールノボラック型エポキシ樹脂、クレゾールノボラック型エポキシ樹脂、ビスフェノールAノボラック型エポキシ樹脂、ビスフェノールFノボラック型エポキシ樹脂、脂環式エポキシ樹脂、脂肪族鎖状エポキシ樹脂、グリシジルエステル型エポキシ樹脂、グリシジルアミン型エポキシ樹脂、ヒダントイン型エポキシ樹脂、イソシアヌレート型エポキシ樹脂、トリフェノールメタン骨格を有するフェノールノボラック型エポキシ樹脂、二官能フェノール類(カテコール、レゾルシノール等)のジグリシジルエーテル化物、二官能アルコール類のジグリシジルエーテル化物、及びそれらのハロゲン化物又は水素添加物などが挙げられる。これらの中でも、本実施形態に係る光硬化性組成物を液晶シール剤として用いる場合には、液晶汚染性の観点から、ビスフェノールA型エポキシ樹脂やレゾルシンジグリシジルエーテルが好ましい。 The epoxy compound is not particularly limited, but a bifunctional or higher functional epoxy compound is preferable. Examples of the bifunctional or higher functional epoxy compound include resorcin diglycidyl ether, bisphenol A type epoxy resin, bisphenol F type epoxy resin, bisphenol S type epoxy resin, phenol novolac type epoxy resin, cresol novolac type epoxy resin, bisphenol A novolak type Epoxy resin, bisphenol F novolac type epoxy resin, alicyclic epoxy resin, aliphatic chain epoxy resin, glycidyl ester type epoxy resin, glycidyl amine type epoxy resin, hydantoin type epoxy resin, isocyanurate type epoxy resin, triphenolmethane skeleton Phenol novolac epoxy resin containing diglycidyl etherified products of bifunctional phenols (catechol, resorcinol, etc.), difunctional alcohols Glycidyl etherified product, and the like thereof halide or hydrogenated product. Among these, when the photocurable composition according to the present embodiment is used as a liquid crystal sealant, bisphenol A type epoxy resin and resorcin diglycidyl ether are preferable from the viewpoint of liquid crystal contamination.
 本実施形態に係る光硬化性組成物が硬化性化合物を含有する場合、その含有率は、光硬化性組成物の総量中、通常10~80質量%であり、好ましくは20~70質量%である。
 また、本実施形態に係る光硬化性組成物がエポキシ化合物を含有する場合、その含有率は、光硬化性組成物の総量中、通常5~50質量%であり、好ましくは5~30質量%である。
When the photocurable composition according to this embodiment contains a curable compound, the content thereof is usually 10 to 80% by mass, preferably 20 to 70% by mass, based on the total amount of the photocurable composition. is there.
When the photocurable composition according to this embodiment contains an epoxy compound, the content is usually 5 to 50% by mass, preferably 5 to 30% by mass, based on the total amount of the photocurable composition. It is.
[有機フィラー]
 本実施形態に係る光硬化性組成物は、有機フィラーを含有していてもよい。有機フィラーは、1種を単独で使用してもよく、2種以上を併用してもよい。
[Organic filler]
The photocurable composition according to the present embodiment may contain an organic filler. An organic filler may be used individually by 1 type, and may use 2 or more types together.
 有機フィラーとしては、例えば、ウレタン微粒子、アクリル微粒子、スチレン微粒子、スチレンオレフィン微粒子、及びシリコーン微粒子が挙げられる。シリコーン微粒子としては、KMP-594、KMP-597、KMP-598(以上、信越化学工業株式会社製);トレフィルRTME-5500、9701、EP-2001(以上、東レ・ダウコーニング株式会社製)が好ましい。ウレタン微粒子としては、JB-800T、HB-800BK(以上、根上工業株式会社製)が好ましい。スチレン微粒子としては、ラバロンRTMT320C、T331C、SJ4400、SJ5400、SJ6400、SJ4300C、SJ5300C、SJ6300C(以上、三菱化学株式会社製)が好ましい。スチレンオレフィン微粒子としては、セプトンRTMSEPS2004、SEPS2063(以上、株式会社クラレ製)が好ましい。これらの有機フィラーは、2種以上の材料を用いたコアシェル構造の有機フィラーであってもよい。 Examples of the organic filler include urethane fine particles, acrylic fine particles, styrene fine particles, styrene olefin fine particles, and silicone fine particles. Examples of the silicone fine particles include KMP-594, KMP-597, KMP-598 (manufactured by Shin-Etsu Chemical Co., Ltd.); Trefill RTM E-5500, 9701, EP-2001 (manufactured by Toray Dow Corning Co., Ltd.). preferable. As urethane fine particles, JB-800T and HB-800BK (manufactured by Negami Industrial Co., Ltd.) are preferable. As the styrene fine particles, Lavalon RTM T320C, T331C, SJ4400, SJ5400, SJ6400, SJ4300C, SJ5300C, and SJ6300C (manufactured by Mitsubishi Chemical Corporation) are preferable. As the styrene olefin fine particles, Septon RTM SEPS 2004 and SEPS 2063 (manufactured by Kuraray Co., Ltd.) are preferable. These organic fillers may be core-shell organic fillers using two or more materials.
 これらの有機フィラーの中でも、アクリル微粒子及びシリコーン微粒子が好ましい。 Among these organic fillers, acrylic fine particles and silicone fine particles are preferable.
 アクリル微粒子としては、2種類のアクリルゴムからなるコアシェル構造のアクリルゴムが好ましく、コア層がn-ブチルアクリレートであり、シェル層がメチルメタクリレートであるものがより好ましい。コア層がn-ブチルアクリレートであり、シェル層がメチルメタクリレートであるアクリル微粒子は、ゼフィアックRTMF-351としてアイカ工業株式会社から販売されている。 As the acrylic fine particles, an acrylic rubber having a core-shell structure composed of two kinds of acrylic rubber is preferable, and the core layer is preferably n-butyl acrylate and the shell layer is more preferably methyl methacrylate. Acrylic fine particles whose core layer is n-butyl acrylate and whose shell layer is methyl methacrylate are sold by Aika Kogyo Co., Ltd. as Zefiac RTM F-351.
 また、シリコーン微粒子としては、オルガノポリシロキサン架橋物粉体、直鎖のジメチルポリシロキサン架橋物粉体、シリコーンゴムの表面にシリコーン樹脂(例えば、ポリオルガノシルセスキオキサン樹脂)を被覆した複合シリコーンゴム等が挙げられる。これらのシリコーン微粒子のうち、好ましいものとしては、直鎖のジメチルポリシロキサン架橋物粉末のシリコーンゴム、又はシリコーン樹脂被覆直鎖ジメチルポリシロキサン架橋物粉末の複合シリコーンゴム微粒子である。ゴム粉末の形状は、添加後の粘度の増粘が少ない球状がよい。 Silicone fine particles include organopolysiloxane cross-linked powder, linear dimethylpolysiloxane cross-linked powder, and a composite silicone rubber in which a silicone resin (for example, polyorganosilsesquioxane resin) is coated on the surface of the silicone rubber. Etc. Among these silicone fine particles, preferred is a silicone rubber of a linear dimethylpolysiloxane crosslinked product powder, or a composite silicone rubber fine particle of a silicone resin-coated linear dimethylpolysiloxane crosslinked product powder. The shape of the rubber powder is preferably a sphere with little increase in viscosity after addition.
 本実施形態に係る光硬化性組成物が有機フィラーを含有する場合、その含有率は、光硬化性組成物の総量中、通常5~50質量%であり、好ましくは5~40質量%である。 When the photocurable composition according to the present embodiment contains an organic filler, the content is usually 5 to 50% by mass, preferably 5 to 40% by mass, based on the total amount of the photocurable composition. .
[無機フィラー]
 本実施形態に係る光硬化性組成物は、無機フィラーを含有していてもよい。無機フィラーは、1種を単独で使用してもよく、2種以上を併用してもよい。
[Inorganic filler]
The photocurable composition according to this embodiment may contain an inorganic filler. An inorganic filler may be used individually by 1 type, and may use 2 or more types together.
 無機フィラーとしては、例えば、シリカ、シリコンカーバイド、窒化珪素、窒化ホウ素、炭酸カルシウム、炭酸マグネシウム、硫酸バリウム、硫酸カルシウム、マイカ、タルク、クレー、アルミナ、酸化マグネシウム、酸化ジルコニウム、水酸化アルミニウム、水酸化マグネシウム、珪酸カルシウム、珪酸アルミニウム、珪酸リチウムアルミニウム、珪酸ジルコニウム、チタン酸バリウム、硝子繊維、炭素繊維、二硫化モリブデン、アスベスト等が挙げられ、好ましくは溶融シリカ、結晶シリカ、窒化珪素、窒化ホウ素、炭酸カルシウム、硫酸バリウム、硫酸カルシウム、マイカ、タルク、クレー、アルミナ、水酸化アルミニウム、珪酸カルシウム、珪酸アルミニウム等の粒子が挙げられ、シリカ、アルミナ、タルク等の粒子が好ましい。 Examples of the inorganic filler include silica, silicon carbide, silicon nitride, boron nitride, calcium carbonate, magnesium carbonate, barium sulfate, calcium sulfate, mica, talc, clay, alumina, magnesium oxide, zirconium oxide, aluminum hydroxide, and hydroxide. Examples include magnesium, calcium silicate, aluminum silicate, lithium aluminum silicate, zirconium silicate, barium titanate, glass fiber, carbon fiber, molybdenum disulfide, asbestos, etc., preferably fused silica, crystalline silica, silicon nitride, boron nitride, carbonic acid Examples of the particles include calcium, barium sulfate, calcium sulfate, mica, talc, clay, alumina, aluminum hydroxide, calcium silicate, and aluminum silicate, and particles such as silica, alumina, and talc are preferable.
 無機フィラーの平均粒子径は、2000nm以下が適当であり、好ましくは1000nm以下、より好ましくは300nm以下である。無機フィラーの平均粒子径を2000nm以下とすることで、例えば、本実施形態に係る光硬化性組成物を液晶滴下工法用液晶シール剤として用いて狭ギャップの液晶セルを製造する際に、上下のガラス基板の貼り合わせ時のギャップ形成がうまくできる傾向にある。また、好ましい下限は10nm程度であり、より好ましくは100nm程度である。粒子径は、レーザー回折・散乱式粒度分布測定器(乾式)(株式会社セイシン企業製;LMS-30)により測定することができる。 The average particle size of the inorganic filler is suitably 2000 nm or less, preferably 1000 nm or less, more preferably 300 nm or less. When the average particle diameter of the inorganic filler is 2000 nm or less, for example, when producing a narrow gap liquid crystal cell using the photocurable composition according to the present embodiment as a liquid crystal sealing agent for a liquid crystal dropping method, the upper and lower There is a tendency that a gap can be formed well when a glass substrate is bonded. Moreover, a preferable minimum is about 10 nm, More preferably, it is about 100 nm. The particle diameter can be measured with a laser diffraction / scattering particle size distribution analyzer (dry type) (manufactured by Seishin Enterprise Co., Ltd .; LMS-30).
 本実施形態に係る光硬化性組成物が無機フィラーを含有する場合、その含有率は、光硬化性組成物の総量中、通常5~50質量%であり、好ましくは5~40質量%である。無機フィラーの含有量を5質量%以上とすることで、ガラス基板に対する接着強度が向上し、また耐湿信頼性も向上するために、吸湿後の接着強度の低下が抑えられる傾向にある。無機フィラーの含有量を50質量%以下とすることで、例えば、本実施形態に係る光硬化性組成物を液晶滴下工法用液晶シール剤として用いて液晶セルを製造する際に、無機フィラーが潰れやすくなり、うまくできる傾向にある。 When the photocurable composition according to the present embodiment contains an inorganic filler, the content is usually 5 to 50% by mass, preferably 5 to 40% by mass, based on the total amount of the photocurable composition. . By setting the content of the inorganic filler to 5% by mass or more, the adhesive strength to the glass substrate is improved and the moisture resistance reliability is also improved, so that a decrease in the adhesive strength after moisture absorption tends to be suppressed. When the content of the inorganic filler is 50% by mass or less, for example, when the liquid crystal cell is produced using the photocurable composition according to the present embodiment as a liquid crystal sealing agent for a liquid crystal dropping method, the inorganic filler is crushed. It tends to be easier and better.
[シランカップリング剤]
 本実施形態に係る光硬化性組成物は、接着強度や耐湿性の向上を図るため、シランカップリング剤を含有していてもよい。シランカップリング剤は、1種を単独で使用してもよく、2種以上を併用してもよい。
[Silane coupling agent]
The photocurable composition according to this embodiment may contain a silane coupling agent in order to improve adhesive strength and moisture resistance. A silane coupling agent may be used individually by 1 type, and may use 2 or more types together.
 シランカップリング剤としては、例えば、3-グリシドキシプロピルトリメトキシシラン、3-グリシドキシプロピルメチルジメトキシシラン、3-グリシドキシプロピルメチルジエトキシシラン、2-(3,4-エポキシシクロヘキシル)エチルトリメトキシシラン、N-フェニル-γ-アミノプロピルトリメトキシシラン、N-(2-アミノエチル)3-アミノプロピルメチルジメトキシシラン、N-(2-アミノエチル)3-アミノプロピルメチルトリメトキシシラン、3-アミノプロピルトリエトキシシラン、3-メルカプトプロピルトリメトキシシラン、ビニルトリメトキシシラン、N-(2-(ビニルベンジルアミノ)エチル)3-アミノプロピルトリメトキシシラン塩酸塩、3-メタクリロキシプロピルトリメトキシシラン、3-クロロプロピルメチルジメトキシシラン、3-クロロプロピルトリメトキシシラン等が挙げられる。これらのシランカップリング剤は、KBMシリーズ、KBEシリーズ等として信越化学工業株式会社等によって販売されているため、市場から容易に入手可能である。 Examples of silane coupling agents include 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, and 2- (3,4-epoxycyclohexyl). Ethyltrimethoxysilane, N-phenyl-γ-aminopropyltrimethoxysilane, N- (2-aminoethyl) 3-aminopropylmethyldimethoxysilane, N- (2-aminoethyl) 3-aminopropylmethyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-mercaptopropyltrimethoxysilane, vinyltrimethoxysilane, N- (2- (vinylbenzylamino) ethyl) 3-aminopropyltrimethoxysilane hydrochloride, 3-methacryloxypropyltrimethoxy Silane 3-chloropropyl methyl dimethoxy silane, 3-chloropropyl trimethoxy silane, and the like. Since these silane coupling agents are sold by Shin-Etsu Chemical Co., Ltd. as KBM series, KBE series, etc., they are easily available from the market.
 本実施形態に係る光硬化性組成物がシランカップリング剤を含有する場合、その含有率は、光硬化性組成物の総量中、0.05~3質量%が好適である。 When the photocurable composition according to this embodiment contains a silane coupling agent, the content is preferably 0.05 to 3% by mass in the total amount of the photocurable composition.
[熱硬化剤]
 本実施形態に係る光硬化性組成物は、熱硬化剤を含有していてもよい。熱硬化剤は、1種を単独で使用してもよく、2種以上を併用してもよい。
[Thermosetting agent]
The photocurable composition according to this embodiment may contain a thermosetting agent. A thermosetting agent may be used individually by 1 type, and may use 2 or more types together.
 熱硬化剤は、非共有電子対や分子内のアニオンによって、求核的に反応するものであり、例えば、多価アミン類、多価フェノール類、有機酸ヒドラジド化合物等を挙げることができる。これらの中でも、有機酸ヒドラジド化合物が好適に用いられる。 The thermosetting agent reacts nucleophilically with an unshared electron pair or an anion in the molecule, and examples thereof include polyvalent amines, polyhydric phenols, and organic acid hydrazide compounds. Among these, organic acid hydrazide compounds are preferably used.
 有機酸ヒドラジド化合物のうち芳香族ヒドラジド化合物としては、例えば、テレフタル酸ジヒドラジド、イソフタル酸ジヒドラジド、2,6-ナフトエ酸ジヒドラジド、2,6-ピリジンジヒドラジド、1,2,4-ベンゼントリヒドラジド、1,4,5,8-ナフトエ酸テトラヒドラジド、ピロメリット酸テトラヒドラジド等が挙げられる。また、有機酸ヒドラジド化合物のうち脂肪族ヒドラジド化合物としては、例えば、ホルムヒドラジド、アセトヒドラジド、プロピオン酸ヒドラジド、シュウ酸ジヒドラジド、マロン酸ジヒドラジド、コハク酸ジヒドラジド、グルタル酸ジヒドラジド、アジピン酸ジヒドラジド、ピメリン酸ジヒドラジド、セバシン酸ジヒドラジド、1,4-シクロヘキサンジヒドラジド、酒石酸ジヒドラジド、リンゴ酸ジヒドラジド、イミノジ酢酸ジヒドラジド、N,N’-ヘキサメチレンビスセミカルバジド、クエン酸トリヒドラジド、ニトリロ酢酸トリヒドラジド、シクロヘキサントリカルボン酸トリヒドラジド、1,3-ビス(ヒドラジノカルボノエチル)-5-イソプロピルヒダントイン等のヒダントイン骨格、好ましくはバリンヒダントイン骨格(ヒダントイン環の炭素原子がイソプロピル基で置換された骨格)を有するジヒドラジド化合物、トリス(1-ヒドラジノカルボニルメチル)イソシアヌレート、トリス(2-ヒドラジノカルボニルエチル)イソシアヌレート、トリス(1-ヒドラジノカルボニルエチル)イソシアヌレート、トリス(3-ヒドラジノカルボニルプロピル)イソシアヌレート、ビス(2-ヒドラジノカルボニルエチル)イソシアヌレート等が挙げられる。 Among the organic acid hydrazide compounds, examples of the aromatic hydrazide compound include terephthalic acid dihydrazide, isophthalic acid dihydrazide, 2,6-naphthoic acid dihydrazide, 2,6-pyridinedihydrazide, 1,2,4-benzenetrihydrazide, 1, Examples include 4,5,8-naphthoic acid tetrahydrazide and pyromellitic acid tetrahydrazide. Examples of the aliphatic hydrazide compound among the organic acid hydrazide compounds include form hydrazide, acetohydrazide, propionic acid hydrazide, oxalic acid dihydrazide, malonic acid dihydrazide, succinic acid dihydrazide, glutaric acid dihydrazide, adipic acid dihydrazide, and pimelic acid dihydrazide. , Sebacic acid dihydrazide, 1,4-cyclohexanedihydrazide, tartaric acid dihydrazide, malic acid dihydrazide, iminodiacetic acid dihydrazide, N, N′-hexamethylenebissemicarbazide, citric acid trihydrazide, nitriloacetic acid trihydrazide, cyclohexanetricarboxylic acid trihydrazide, 1 , 3-bis (hydrazinocarbonoethyl) -5-isopropylhydantoin and the like, preferably a valine hydantoin skeleton ( Dihydrazide compounds having a skeleton in which the carbon atom of the danttoin ring is substituted with an isopropyl group), tris (1-hydrazinocarbonylmethyl) isocyanurate, tris (2-hydrazinocarbonylethyl) isocyanurate, tris (1-hydrazinocarbonyl) And ethyl) isocyanurate, tris (3-hydrazinocarbonylpropyl) isocyanurate, and bis (2-hydrazinocarbonylethyl) isocyanurate.
 有機酸ヒドラジド化合物の中でも、硬化反応性と潜在性とのバランスから、イソフタル酸ジヒドラジド、マロン酸ジヒドラジド、アジピン酸ジヒドラジド、トリス(1-ヒドラジノカルボニルメチル)イソシアヌレート、トリス(1-ヒドラジノカルボニルエチル)イソシアヌレート、トリス(2-ヒドラジノカルボニルエチル)イソシアヌレート、及びトリス(3-ヒドラジノカルボニルプロピル)イソシアヌレートが好ましく、トリス(2-ヒドラジノカルボニルエチル)イソシアヌレートがより好ましい。 Among organic acid hydrazide compounds, isophthalic acid dihydrazide, malonic acid dihydrazide, adipic acid dihydrazide, tris (1-hydrazinocarbonylmethyl) isocyanurate, tris (1-hydrazinocarbonylethyl) are selected from the balance between curing reactivity and potential. ) Isocyanurate, tris (2-hydrazinocarbonylethyl) isocyanurate, and tris (3-hydrazinocarbonylpropyl) isocyanurate are preferred, and tris (2-hydrazinocarbonylethyl) isocyanurate is more preferred.
 本実施形態に係る光硬化性組成物が熱硬化剤を含有する場合、その含有率は、光硬化性組成物の総量中、通常0.1~10質量%であり、好ましくは1~5質量%である。 When the photocurable composition according to the present embodiment contains a thermosetting agent, the content is usually 0.1 to 10% by mass, preferably 1 to 5% by mass, based on the total amount of the photocurable composition. %.
[熱ラジカル重合開始剤]
 本実施形態に係る光硬化性組成物は、硬化速度及び硬化性を向上するため、熱ラジカル重合開始剤を含有していてもよい。熱ラジカル重合開始剤は、1種を単独で使用してもよく、2種以上を併用してもよい。
[Thermal radical polymerization initiator]
The photocurable composition according to this embodiment may contain a thermal radical polymerization initiator in order to improve the curing rate and curability. A thermal radical polymerization initiator may be used individually by 1 type, and may use 2 or more types together.
 熱ラジカル重合開始剤としては、加熱によりラジカルを生じ、連鎖重合反応を開始させる化合物であれば特に限定されず、有機過酸化物、アゾ化合物、ベンゾイン化合物、ベンゾインエーテル化合物、アセトフェノン化合物、ベンゾピナコール等が挙げられ、ベンゾピナコールが好適に用いられる。 The thermal radical polymerization initiator is not particularly limited as long as it is a compound that generates radicals by heating and initiates a chain polymerization reaction, such as organic peroxide, azo compound, benzoin compound, benzoin ether compound, acetophenone compound, benzopinacol, etc. And benzopinacol is preferably used.
 有機過酸化物の市販品としては、カヤメックRTMA、M、R、L、LH、SP-30C、パーカドックスCH-50L、BC-FF、カドックスB-40ES、パーカドックス14、トリゴノックスRTM22-70E、23-C70、121、121-50E、121-LS50E、21-LS50E、42、42LS、カヤエステルRTMP-70、TMPO-70、CND-C70、OO-50E、AN、カヤブチルRTMB、パーカドックス16、カヤカルボンRTMBIC-75、AIC-75(以上、化薬アクゾ株式会社製);パーメックRTMN、H、S、F、D、G、パーヘキサRTMH、HC、TMH、C、V、22、MC、パーキュアーRTMAH、AL、HB、パーブチルRTMH、C、ND、L、パークミルRTMH、D、パーロイルRTMIB、IPP、パーオクタRTMND(以上、日油株式会社製);等が挙げられる。 Commercially available organic peroxides include Kayamek RTM A, M, R, L, LH, SP-30C, Parkadox CH-50L, BC-FF, Cadox B-40ES, Parkadox 14, Trigonox RTM 22-70E. 23-C70, 121, 121-50E, 121-LS50E, 21-LS50E, 42, 42LS, Kayaester RTM P-70, TMPO-70, CND-C70, OO-50E, AN, Kayabutyl RTM B, Parkardox 16, Kayacaron RTM BIC-75, AIC-75 (above, manufactured by Kayaku Akzo Co., Ltd.); Permec RTM N, H, S, F, D, G, Perhexa RTM H, HC, TMH, C, V, 22, MC, Pakyua RTM AH, AL, HB, Perbutyl RTM H, C, ND, L , Pakumi RTM H, D, PEROYL RTM IB, IPP, Perocta RTM ND (manufactured by NOF CORPORATION); and the like.
 また、アゾ化合物の市販品としては、VA-044、086、V-070、VPE-0201、VSP-1001(以上、和光純薬工業株式会社製)等が挙げられる。 Further, examples of commercially available azo compounds include VA-044, 086, V-070, VPE-0201, VSP-1001 (above, manufactured by Wako Pure Chemical Industries, Ltd.) and the like.
 本実施形態に係る光硬化性組成物が熱ラジカル重合開始剤を含有する場合、その含有率は、光硬化性組成物の総量中、通常0.0001~10質量%であり、好ましくは0.0005~5質量%であり、より好ましくは0.001~3質量%である。 When the photocurable composition according to the present embodiment contains a thermal radical polymerization initiator, the content thereof is usually 0.0001 to 10% by mass in the total amount of the photocurable composition, preferably 0.00. It is 0005 to 5% by mass, and more preferably 0.001 to 3% by mass.
[その他の成分]
 本実施形態に係る光硬化性組成物は、必要に応じて、硬化促進剤、ラジカル重合防止剤、顔料、レベリング剤、消泡剤、溶剤などの添加剤を含有していてもよい。
[Other ingredients]
The photocurable composition concerning this embodiment may contain additives, such as a hardening accelerator, a radical polymerization inhibitor, a pigment, a leveling agent, an antifoamer, and a solvent, as needed.
(硬化促進剤)
 硬化促進剤としては、有機酸、イミダゾール等が挙げられる。
 有機酸としては、有機カルボン酸、有機リン酸等が挙げられ、有機カルボン酸が好ましい。具体的には、フタル酸、イソフタル酸、テレフタル酸、トリメリット酸、ベンゾフェノンテトラカルボン酸、フランジカルボン酸、コハク酸、アジピン酸、ドデカン二酸、セバシン酸、チオジプロピオン酸、シクロヘキサンジカルボン酸、トリス(2-カルボキシメチル)イソシアヌレート、トリス(2-カルボキシエチル)イソシアヌレート、トリス(2-カルボキシプロピル)イソシアヌレート、ビス(2-カルボキシエチル)イソシアヌレート等が挙げられる。
 イミダゾール化合物としては、2-メチルイミダゾール、2-フェニルイミダゾール、2-ウンデシルイミダゾール、2-ヘプタデシルイミダゾール、2-フェニル-4-メチルイミダゾール、1-ベンジル-2-フェニルイミダゾール、1-ベンジル-2-メチルイミダゾール、1-シアノエチル-2-メチルイミダゾール、1-シアノエチル-2-フェニルイミダゾール、1-シアノエチル-2-ウンデシルイミダゾール、2,4-ジアミノ-6(2’-メチルイミダゾール(1’))エチル-s-トリアジン、2,4-ジアミノ-6(2’-ウンデシルイミダゾール(1’))エチル-s-トリアジン、2,4-ジアミノ-6(2’-エチル-4-メチルイミダゾール(1’))エチル-s-トリアジン、2,4-ジアミノ-6(2’-メチルイミダゾール(1’))エチル-s-トリアジン・イソシアヌル酸付加物、2-メチルイミダゾールイソシアヌル酸の2:3付加物、2-フェニルイミダゾールイソシアヌル酸付加物、2-フェニル-3,5-ジヒドロキシメチルイミダゾール、2-フェニル-4-ヒドロキシメチル-5-メチルイミダゾール、1-シアノエチル-2-フェニル-3,5-ジシアノエトキシメチルイミダゾール等が挙げられる。
(Curing accelerator)
Examples of the curing accelerator include organic acids and imidazoles.
Examples of the organic acid include organic carboxylic acid and organic phosphoric acid, and organic carboxylic acid is preferable. Specifically, phthalic acid, isophthalic acid, terephthalic acid, trimellitic acid, benzophenone tetracarboxylic acid, furandicarboxylic acid, succinic acid, adipic acid, dodecanedioic acid, sebacic acid, thiodipropionic acid, cyclohexanedicarboxylic acid, tris (2-Carboxymethyl) isocyanurate, tris (2-carboxyethyl) isocyanurate, tris (2-carboxypropyl) isocyanurate, bis (2-carboxyethyl) isocyanurate and the like.
Examples of imidazole compounds include 2-methylimidazole, 2-phenylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-phenylimidazole, and 1-benzyl-2. -Methylimidazole, 1-cyanoethyl-2-methylimidazole, 1-cyanoethyl-2-phenylimidazole, 1-cyanoethyl-2-undecylimidazole, 2,4-diamino-6 (2'-methylimidazole (1 ')) Ethyl-s-triazine, 2,4-diamino-6 (2′-undecylimidazole (1 ′)) ethyl-s-triazine, 2,4-diamino-6 (2′-ethyl-4-methylimidazole (1 ')) Ethyl-s-triazine, 2,4-diamino-6 (2'-methyl) Midazole (1 ')) ethyl-s-triazine isocyanuric acid adduct, 2-methylimidazole isocyanuric acid 2: 3 adduct, 2-phenylimidazole isocyanuric acid adduct, 2-phenyl-3,5-dihydroxymethylimidazole 2-phenyl-4-hydroxymethyl-5-methylimidazole, 1-cyanoethyl-2-phenyl-3,5-dicyanoethoxymethylimidazole and the like.
 本実施形態に係る光硬化性組成物が硬化促進剤を含有する場合、その含有率は、光硬化性組成物の総量中、通常0.1~10質量%であり、好ましくは1~5質量%である。 When the photocurable composition according to this embodiment contains a curing accelerator, the content thereof is usually 0.1 to 10% by mass, preferably 1 to 5% by mass, based on the total amount of the photocurable composition. %.
(ラジカル重合防止剤)
 ラジカル重合防止剤としては、光ラジカル重合開始剤や熱ラジカル重合開始剤等から発生するラジカルと反応して重合を防止する化合物であれば特に限定されるものではなく、キノン系、ピペリジン系、ヒンダードフェノール系、ニトロソ系等のラジカル重合防止剤が挙げられる。具体的には、ナフトキノン、2-ヒドロキシナフトキノン、2-メチルナフトキノン、2-メトキシナフトキノン、2,2,6,6-テトラメチルピペリジン-1-オキシル、2,2,6,6-テトラメチル-4-ヒドロキシピペリジン-1-オキシル、2,2,6,6,-テトラメチル-4-メトキシピペリジン-1-オキシル、2,2,6,6-テトラメチル-4-フェノキシピペリジン-1-オキシル、ハイドロキノン、2-メチルハイドロキノン、2-メトキシハイドロキノン、パラベンゾキノン、ブチル化ヒドロキシアニソール、2,6-ジ-t-ブチル-4-エチルフェノール、2,6-ジ-t-ブチルクレゾール、ステアリルβ-(3,5-ジ-t-ブチル-4-ヒドロキシフェニル)プロピオネート、2,2’-メチレンビス(4-エチル-6-t-ブチルフェノール)、4,4’-チオビス(3-メチル-6-t-ブチルフェノール)、4,4’-ブチリデンビス(3-メチル-6-t-ブチルフェノール)、3,9-ビス[1,1-ジメチル-2-[β―(3-t-ブチル-4-ヒドロキシ-5-メチルフェニル)プロピオニルオキシ]エチル]、2,4,8,10-テトラオキサスピロ[5,5]ウンデカン、テトラキス-[メチレン-3-(3’,5’-ジ-t-ブチル-4’-ヒドロキシフェニルプロピオネート)]メタン、1,3,5-トリス(3’,5’-ジ-t-ブチル-4’-ヒドロキシベンジル)-sec-トリアジン-2,4,6-(1H,3H,5H)トリオン、パラメトキシフェノール、4-メトキシ-1-ナフトール、チオジフェニルアミン、N-ニトロソフェニルヒドロキシアミンのアルミニウム塩、商品名アデカスタブLA-81、商品名アデカスタブLA-82(いずれも株式会社アデカ製)等が挙げられる。これらの中でも、ナフトキノン系、ハイドロキノン系、ニトロソ系、ピペリジン系のラジカル重合防止剤が好ましく、ナフトキノン、2-ヒドロキシナフトキノン、ハイドロキノン、2,6-ジ-tert-ブチル-p-クレゾール、ポリストップ7300P(伯東株式会社製)がより好ましく、ポリストップ7300P(伯東株式会社製)がさらに好ましい。
(Radical polymerization inhibitor)
The radical polymerization inhibitor is not particularly limited as long as it is a compound that prevents polymerization by reacting with radicals generated from a photo radical polymerization initiator or a thermal radical polymerization initiator, and is not limited to quinone, piperidine, hinders. Examples include radical polymerization inhibitors such as dophenol and nitroso. Specifically, naphthoquinone, 2-hydroxynaphthoquinone, 2-methylnaphthoquinone, 2-methoxynaphthoquinone, 2,2,6,6-tetramethylpiperidine-1-oxyl, 2,2,6,6-tetramethyl-4 -Hydroxypiperidine-1-oxyl, 2,2,6,6, -tetramethyl-4-methoxypiperidine-1-oxyl, 2,2,6,6-tetramethyl-4-phenoxypiperidine-1-oxyl, hydroquinone 2-methylhydroquinone, 2-methoxyhydroquinone, parabenzoquinone, butylated hydroxyanisole, 2,6-di-t-butyl-4-ethylphenol, 2,6-di-t-butylcresol, stearyl β- (3 , 5-Di-tert-butyl-4-hydroxyphenyl) propionate, 2,2'-methylenebis 4-ethyl-6-tert-butylphenol), 4,4′-thiobis (3-methyl-6-tert-butylphenol), 4,4′-butylidenebis (3-methyl-6-tert-butylphenol), 3,9 -Bis [1,1-dimethyl-2- [β- (3-tert-butyl-4-hydroxy-5-methylphenyl) propionyloxy] ethyl], 2,4,8,10-tetraoxaspiro [5 5] Undecane, tetrakis- [methylene-3- (3 ′, 5′-di-t-butyl-4′-hydroxyphenylpropionate)] methane, 1,3,5-tris (3 ′, 5′-di -T-butyl-4'-hydroxybenzyl) -sec-triazine-2,4,6- (1H, 3H, 5H) trione, paramethoxyphenol, 4-methoxy-1-naphthol, thiodiphenylamine, N- Toro Seo aluminum salts of phenyl hydroxylamine, trade name ADK STAB LA-81, include the trade name ADK STAB LA-82 (all manufactured by Ltd. Adeka) and the like. Of these, naphthoquinone, hydroquinone, nitroso, and piperidine radical polymerization inhibitors are preferred, and naphthoquinone, 2-hydroxynaphthoquinone, hydroquinone, 2,6-di-tert-butyl-p-cresol, polystop 7300P ( Hakuto Co., Ltd.) is more preferable, and Polystop 7300P (Hakuto Co., Ltd.) is more preferable.
 本実施形態に係る光硬化性組成物がラジカル重合防止剤を含有する場合、その含有率は、光硬化性組成物の総量中、通常0.0001~1質量%であり、好ましくは0.001~0.5質量%であり、より好ましくは0.01~0.2質量%である。 When the photocurable composition according to this embodiment contains a radical polymerization inhibitor, the content thereof is usually 0.0001 to 1% by mass, preferably 0.001 in the total amount of the photocurable composition. It is -0.5 mass%, More preferably, it is 0.01-0.2 mass%.
[光硬化性組成物の粘度]
 本実施形態に係る光硬化性組成物の25℃における粘度は、150~500Pa・sが好ましく、200~500Pa・sがより好ましい。特に、本実施形態に係る光硬化性組成物を液晶シール剤として用いる場合、光硬化性組成物の25℃における粘度は、250~400Pa・sが好ましく、280~320Pa・sがより好ましい。粘度を250Pa・s以上とすることで、液晶の差し込みの発生が抑えられ、セル化が容易になる傾向にある。粘度を400Pa・s以下とすることで、液晶シール剤の塗布が容易になる傾向にある。
[Viscosity of photocurable composition]
The viscosity at 25 ° C. of the photocurable composition according to this embodiment is preferably 150 to 500 Pa · s, more preferably 200 to 500 Pa · s. In particular, when the photocurable composition according to this embodiment is used as a liquid crystal sealant, the viscosity of the photocurable composition at 25 ° C. is preferably 250 to 400 Pa · s, and more preferably 280 to 320 Pa · s. By setting the viscosity to 250 Pa · s or more, occurrence of liquid crystal insertion is suppressed, and cell formation tends to be facilitated. When the viscosity is 400 Pa · s or less, application of the liquid crystal sealant tends to be easy.
[光硬化性組成物の調製方法]
 本実施形態に係る光硬化性組成物の調製方法の一例としては、次に示す方法が挙げられる。まず、硬化性化合物に、上記式(1)で表される化合物を加熱溶解する。次いで、室温まで冷却した後、必要に応じて、有機フィラー、無機フィラー、シランカップリング剤、熱硬化剤、熱ラジカル重合開始剤、消泡剤、レベリング剤、溶剤等を添加する。そして、3本ロール、サンドミル、ボールミル等の公知の混合装置により均一に混合し、金属メッシュにて濾過することにより、本実施形態に係る光硬化性組成物を調製することができる。
[Method for Preparing Photocurable Composition]
Examples of the method for preparing the photocurable composition according to this embodiment include the following methods. First, the compound represented by the formula (1) is heated and dissolved in the curable compound. Subsequently, after cooling to room temperature, an organic filler, an inorganic filler, a silane coupling agent, a thermosetting agent, a thermal radical polymerization initiator, an antifoaming agent, a leveling agent, a solvent, etc. are added as needed. And the photocurable composition which concerns on this embodiment can be prepared by mixing uniformly with well-known mixing apparatuses, such as a 3 roll, a sand mill, and a ball mill, and filtering with a metal mesh.
[光硬化性組成物の用途等]
 本実施形態に係る光硬化性組成物は、電子部品用封止剤又は電子部品用接着剤として非常に有用である。電子部品用封止剤又は電子部品用接着剤としては、フレキシブルプリント配線板用接着剤、TAB用接着剤、半導体用接着剤、各種ディスプレイ用接着剤等が挙げられるが、これらに限定されるものではない。
[Uses of photocurable composition, etc.]
The photocurable composition according to the present embodiment is very useful as an electronic component sealant or an electronic component adhesive. Examples of the electronic component sealant or the electronic component adhesive include, but are not limited to, flexible printed wiring board adhesives, TAB adhesives, semiconductor adhesives, various display adhesives, and the like. is not.
 また、本実施形態に係る光硬化性組成物は、液晶表示セル用接着剤として、特に液晶シール剤として非常に有用である。本実施形態に係る光硬化性組成物を液晶シール剤として用いた場合の液晶表示セルについて、以下に例を示す。 Also, the photocurable composition according to this embodiment is very useful as an adhesive for liquid crystal display cells, particularly as a liquid crystal sealant. An example is shown below about the liquid crystal display cell at the time of using the photocurable composition which concerns on this embodiment as a liquid-crystal sealing compound.
 液晶表示セル用接着剤を用いて製造される液晶表示セルは、基板に所定の電極を形成した一対の基板を所定の間隔に対向配置し、周囲を液晶シール剤でシールし、その間隙に液晶が封入されたものである。封入される液晶の種類は特に限定されない。基板は、ガラス、石英、プラスチック、シリコーン等からなる少なくとも一方に光透過性がある組み合わせの基板から構成される。 A liquid crystal display cell manufactured using an adhesive for a liquid crystal display cell has a pair of substrates each having a predetermined electrode formed on the substrate opposed to each other at a predetermined interval, and the periphery is sealed with a liquid crystal sealant, and a liquid crystal is interposed in the gap. Is enclosed. The kind of liquid crystal to be sealed is not particularly limited. The substrate is composed of a combination of substrates made of at least one of glass, quartz, plastic, silicone, etc. and having light transmission properties.
 液晶表示セルの製造方法は、例えば以下のとおりである。
 まず、液晶シール剤にスペーサ(間隙制御材)を添加する。スペーサとしては、グラスファイバー、シリカビーズ、ポリマービーズ等が挙げられる。スペーサの直径は目的に応じ異なるが、通常2~8μm、好ましくは4~7μmである。その使用量は、液晶シール剤100質量部に対し、通常0.1~4質量部であり、好ましくは0.5~2質量部であり、より好ましくは0.9~1.5質量部程度である。
The manufacturing method of a liquid crystal display cell is as follows, for example.
First, a spacer (gap control material) is added to the liquid crystal sealant. Examples of the spacer include glass fiber, silica beads, and polymer beads. The diameter of the spacer varies depending on the purpose, but is usually 2 to 8 μm, preferably 4 to 7 μm. The amount of use is usually 0.1 to 4 parts by mass, preferably 0.5 to 2 parts by mass, more preferably about 0.9 to 1.5 parts by mass with respect to 100 parts by mass of the liquid crystal sealant. It is.
 次いで、一対の基板の一方にディスペンサー、スクリーン印刷装置等を用いて液晶シール剤を塗布した後、必要に応じて80~120℃で仮硬化を行う。その後、液晶シール剤の堰の内側に液晶を滴下し、真空中にてもう一方のガラス基板を重ね合わせ、ギャップ出しを行う。ギャップ形成後、90~130℃で1~2時間硬化することにより、液晶表示セルを得ることができる。また、光熱併用型として使用する場合は、紫外線照射機により液晶シール剤に紫外線を照射させて光硬化させる。紫外線照射量は、好ましくは500~6000mJ/cm、より好ましくは1000~4000mJ/cmである。その後、必要に応じて90~130℃で1~2時間硬化することにより、液晶表示セルを得ることができる。このようにして得られた液晶表示セルは、液晶汚染による表示不良がなく、接着性及び耐湿信頼性に優れたものである。 Next, after applying a liquid crystal sealant to one of the pair of substrates using a dispenser, a screen printing apparatus, or the like, temporary curing is performed at 80 to 120 ° C. as necessary. Thereafter, the liquid crystal is dropped inside the weir of the liquid crystal sealant, and the other glass substrate is overlaid in a vacuum to create a gap. After forming the gap, the liquid crystal display cell can be obtained by curing at 90 to 130 ° C. for 1 to 2 hours. When used as a photothermal combination type, the liquid crystal sealant is irradiated with ultraviolet rays by an ultraviolet irradiator and photocured. The amount of ultraviolet irradiation is preferably 500 to 6000 mJ / cm 2 , more preferably 1000 to 4000 mJ / cm 2 . Thereafter, if necessary, it is cured at 90 to 130 ° C. for 1 to 2 hours to obtain a liquid crystal display cell. The liquid crystal display cell thus obtained does not have a display defect due to liquid crystal contamination, and has excellent adhesion and moisture resistance reliability.
 本実施形態に係る光硬化性組成物は、遮光部を有する設計の電子部品や可視光のような低エネルギー光で硬化する必要のある接着剤用途の使用に非常に適するものである。例えば、配線遮光部下で用いられる液晶表示用シール剤、有機EL用封止剤、タッチパネル用接着剤として好適である。 The photocurable composition according to the present embodiment is very suitable for use in an electronic component designed to have a light-shielding portion and an adhesive application that needs to be cured with low energy light such as visible light. For example, it is suitable as a liquid crystal display sealing agent, an organic EL sealing agent, and a touch panel adhesive used under a wiring light shielding portion.
 以下、実施例により本発明をさらに詳細に説明するが、本発明は実施例に限定されるものではない。なお、特別の記載のない限り、本文中「%」とあるのは質量基準である。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the examples. Unless otherwise specified, “%” in the text is based on mass.
<実施例1>
[合成例1:2-アセチルチオキサントンの合成]
<Example 1>
[Synthesis Example 1: Synthesis of 2-acetylthioxanthone]
Figure JPOXMLDOC01-appb-C000005
Figure JPOXMLDOC01-appb-C000005
 2-アセチルチオキサントンは、先行文献(Material Technology,Vol.27,No.6(2009),pp.242-251)記載の合成手順に従い合成した。 2-Acetylthioxanthone was synthesized according to the synthesis procedure described in the prior literature (Material Technology, Vol. 27, No. 6 (2009), pp. 242-251).
[合成例2:TX-OXE(化合物番号1)の合成] [Synthesis Example 2: Synthesis of TX-OXE (Compound No. 1)]
Figure JPOXMLDOC01-appb-C000006
Figure JPOXMLDOC01-appb-C000006
 200mLの4つ口反応容器に温度計及び冷却管を設置し、流速30mL/minで窒素フローを開始した。反応容器に2-アセチルチオキサントン(0.50g)、ヒドロキシルアミン塩酸塩(0.20g)、及びN,N-ジメチルホルムアミド(60mL)を加え、80℃で4時間反応を行った。水50mLを加えて反応を停止させ、メチルイソブチルケトン(200mL)で抽出し、水50mLで3回水洗した。エバポレータを用いて溶剤を除去し、2-アセチルチオキサントンのオキシム化体(TX-OX/黄色固体)を得た。ここで得られた黄色固体(粗結晶)をそのままオキシムエステル化反応に用いた。 A thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min. 2-Acetylthioxanthone (0.50 g), hydroxylamine hydrochloride (0.20 g), and N, N-dimethylformamide (60 mL) were added to the reaction vessel and reacted at 80 ° C. for 4 hours. The reaction was stopped by adding 50 mL of water, extracted with methyl isobutyl ketone (200 mL), and washed with 50 mL of water three times. The solvent was removed using an evaporator to obtain an oxime product of 2-acetylthioxanthone (TX-OX / yellow solid). The yellow solid (crude crystals) obtained here was used for the oxime esterification reaction as it was.
Figure JPOXMLDOC01-appb-C000007
Figure JPOXMLDOC01-appb-C000007
 200mLの4つ口反応容器に温度計及び冷却管を設置し、流速30mL/minで窒素フローを開始した。反応容器にTX-OXの全量、無水酢酸(0.24g)、及び酢酸ブチル(30mL)を加え、90℃で5時間反応を行った。水50mLを加えて反応を停止させ、メチルイソブチルケトン(200mL)で抽出し、水50mLで3回水洗した。エバポレータを用いて溶剤を除去し、黄色固体を得た。ここで得られた黄色固体をアセトン及び水で再結晶し、2-アセチルチオキサントンのオキシムエステル体(TX-OXE/黄色固体)を0.35g(2段階反応の収率:57%)得た。
H-NMR(400MHz,DMSO-d6);δ(ppm)2.30(s,3H),2.51(s,3H),7.53(ddd,1H)7.59-7.6(m,2H),7.64-7.68(m,1H),8.25(dd,1H),8.60-8.66(m,1H),8.85(d,1H)
A thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min. A total amount of TX-OX, acetic anhydride (0.24 g), and butyl acetate (30 mL) were added to the reaction vessel, and the reaction was carried out at 90 ° C. for 5 hours. The reaction was stopped by adding 50 mL of water, extracted with methyl isobutyl ketone (200 mL), and washed with 50 mL of water three times. The solvent was removed using an evaporator to obtain a yellow solid. The yellow solid obtained here was recrystallized from acetone and water to obtain 0.35 g of 2-acetylthioxanthone oxime ester (TX-OXE / yellow solid) (yield of two-step reaction: 57%).
1 H-NMR (400 MHz, DMSO-d6); δ (ppm) 2.30 (s, 3H), 2.51 (s, 3H), 7.53 (ddd, 1H) 7.59-7.6 ( m, 2H), 7.64-7.68 (m, 1H), 8.25 (dd, 1H), 8.60-8.66 (m, 1H), 8.85 (d, 1H)
[合成例3:TX-OXE-2(化合物番号20)の合成] [Synthesis Example 3: Synthesis of TX-OXE-2 (Compound No. 20)]
Figure JPOXMLDOC01-appb-C000008
Figure JPOXMLDOC01-appb-C000008
 200mLの4つ口反応容器に温度計及び冷却管を設置し、流速30mL/minで窒素フローを開始した。反応容器にTX-OX(0.5g)、塩化ベンゾイル(0.52g)、トリエチルアミン(0.47g)、及びテトラヒドロフラン(30mL)を加え、55℃で8時間反応を行った。水30mLを加えて反応を停止させ、析出した固体を濾過で分取した。ここで得られた黄色固体をジメチルスルホキシド及び水で再結晶し、2-アセチルチオキサントンのオキシムエステル体(TX-OXE-2/黄色固体)を0.28g(収率:40%)得た。
H-NMR(400MHz,DMSO-d6);δ(ppm)2.65(s,3H),7.58-7.67(m,3H),7.72-7.85(m,2H)7.89-8.28(m,5H),8.51(d,1H),8.85(s,1H)
A thermometer and a cooling pipe were installed in a 200 mL four-necked reaction vessel, and a nitrogen flow was started at a flow rate of 30 mL / min. TX-OX (0.5 g), benzoyl chloride (0.52 g), triethylamine (0.47 g), and tetrahydrofuran (30 mL) were added to the reaction vessel, and the reaction was carried out at 55 ° C. for 8 hours. The reaction was stopped by adding 30 mL of water, and the precipitated solid was collected by filtration. The yellow solid obtained here was recrystallized with dimethyl sulfoxide and water to obtain 0.28 g (yield: 40%) of 2-acetylthioxanthone oxime ester (TX-OXE-2 / yellow solid).
1 H-NMR (400 MHz, DMSO-d6); δ (ppm) 2.65 (s, 3H), 7.58-7.67 (m, 3H), 7.72-7.85 (m, 2H) 7.89-8.28 (m, 5H), 8.51 (d, 1H), 8.85 (s, 1H)
<実施例2及び3>
 下記表1に示す硬化性化合物(B-1、B-2、B-3)を混合し、下記表1に示す光重合開始剤(A-1)を90℃で加熱溶解させた後、室温まで冷却した。次いで、下記表1の残りの成分を添加して撹拌した後、3本ロールミルにて分散させた。その後、金属メッシュ(635メッシュ)で濾過することにより、実施例2及び3の光硬化性組成物を調製した。なお、表1中の各成分の数値は質量部を表す。
<Examples 2 and 3>
The curable compounds (B-1, B-2, B-3) shown in Table 1 below were mixed and the photopolymerization initiator (A-1) shown in Table 1 below was heated and dissolved at 90 ° C. Until cooled. Next, the remaining components in Table 1 below were added and stirred, and then dispersed in a three-roll mill. Then, the photocurable composition of Example 2 and 3 was prepared by filtering with a metal mesh (635 mesh). In addition, the numerical value of each component in Table 1 represents a mass part.
<比較例1及び2>
 光重合開始剤(A-1)の代わりに下記表1に示すその他の成分(O-2、O-3)を用いたほかは実施例2及び3と同様にして、比較例1及び2の光硬化性組成物を調製した。
<Comparative Examples 1 and 2>
In the same manner as in Examples 2 and 3, except that other components (O-2, O-3) shown in Table 1 below were used in place of the photopolymerization initiator (A-1), Comparative Examples 1 and 2 A photocurable composition was prepared.
<評価>
[遮光部硬化幅(紫外線照射)]
 実施例2及び3、比較例1及び2の各光硬化性組成物に4μmのグラスファイバー(日本電気硝子株式会社製)を1質量%添加し、液晶シール剤を調製した。クロムをエッチングすることによって100μmのライン及びスペースを設けたガラス基板に液晶シール剤を塗布し、対向基板としてブラックマトリクス基板を貼り合わせた。次いで、ライン/スペースを設けた基板側から波長365nmの紫外光を3000mJ/cm(100mW/cmで30秒)の照射量で照射し、顕微鏡にて硬化幅を測定した。結果を下記表1に示す。
<Evaluation>
[Light-shielding part curing width (UV irradiation)]
1% by mass of 4 μm glass fiber (manufactured by Nippon Electric Glass Co., Ltd.) was added to each of the photocurable compositions of Examples 2 and 3 and Comparative Examples 1 and 2, to prepare a liquid crystal sealant. A liquid crystal sealant was applied to a glass substrate provided with 100 μm lines and spaces by etching chromium, and a black matrix substrate was bonded as a counter substrate. Next, ultraviolet light having a wavelength of 365 nm was irradiated from the substrate side provided with the line / space at an irradiation amount of 3000 mJ / cm 2 (100 mW / cm 2 for 30 seconds), and the curing width was measured with a microscope. The results are shown in Table 1 below.
[遮光部硬化幅(可視光照射)]
 実施例2及び3、比較例1及び2の各光硬化性組成物に4μmのグラスファイバー(日本電気硝子株式会社製)を1質量%添加し、液晶シール剤を調製した。クロムをエッチングすることによって100μmのライン及びスペースを設けたガラス基板に液晶シール剤を塗布し、対向基板としてブラックマトリクス基板を貼り合わせた。次いで、ライン/スペースを設けた基板側から波長405nmの可視光を3000mJ/cm(100mW/cmで30秒)の照射量で照射し、顕微鏡にて硬化幅を測定した。結果を下記表1に示す。
[Light-shielding part curing width (visible light irradiation)]
1% by mass of 4 μm glass fiber (manufactured by Nippon Electric Glass Co., Ltd.) was added to each of the photocurable compositions of Examples 2 and 3 and Comparative Examples 1 and 2, to prepare a liquid crystal sealant. A liquid crystal sealant was applied to a glass substrate provided with 100 μm lines and spaces by etching chromium, and a black matrix substrate was bonded as a counter substrate. Next, visible light having a wavelength of 405 nm was irradiated at a dose of 3000 mJ / cm 2 (100 mW / cm 2 for 30 seconds) from the side of the substrate on which the line / space was provided, and the curing width was measured with a microscope. The results are shown in Table 1 below.
[粘度]
 E型粘度計(R115型粘度計(東機産業株式会社製))により実施例2及び3、比較例1及び2の各光硬化性組成物の25℃における粘度(Pa・s)を測定した。結果を下記表1に示す。
[viscosity]
The viscosity (Pa · s) at 25 ° C. of each of the photocurable compositions of Examples 2 and 3 and Comparative Examples 1 and 2 was measured with an E-type viscometer (R115 viscometer (manufactured by Toki Sangyo Co., Ltd.)). . The results are shown in Table 1 below.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 表1に示されるように、光重合開始剤としてTX-OXEを用いた実施例2及び3の光硬化性組成物は、類似構造を有する光重合開始剤を用いた比較用1及び2の光硬化性組成物に比べて、紫外線でも可視光でも深部(低エネルギー照射部分)での硬化性が良好であった。すなわち、実施例2及び3の光硬化性組成物は、低エネルギーでの優れた硬化性を有することが確認された。

 
As shown in Table 1, the photocurable compositions of Examples 2 and 3 using TX-OXE as a photopolymerization initiator are the same as those of Comparative Examples 1 and 2 using a photopolymerization initiator having a similar structure. Compared with the curable composition, the curability in the deep part (low energy irradiated part) was good in both ultraviolet and visible light. That is, it was confirmed that the photocurable compositions of Examples 2 and 3 have excellent curability at low energy.

Claims (13)

  1.  下記式(1)で表される化合物。
    Figure JPOXMLDOC01-appb-C000001
    [式(1)中、R及びRはそれぞれ独立して、水素原子、カルボキシ基、スルホ基、ヒドロキシ基、アセチルアミノ基、ハロゲン原子、シアノ基、ニトロ基、スルファモイル基、(C1-C8)アルキル基、又は(C1-C8)アルコキシ基を表し、Rは(C1-C8)アルキル基又は(C1-C8)アルコキシ基を表し、Rは水素原子、(C1-C8)アルキル基、(C2-C8)アルケニル基、アリール基、又はヘテロアリール基を表す。RとRとが互いに結合して環状構造を形成していてもよい。また、R同士で結合して2量体を形成していてもよい。]
    A compound represented by the following formula (1).
    Figure JPOXMLDOC01-appb-C000001
    [In Formula (1), R 1 and R 2 are each independently a hydrogen atom, a carboxy group, a sulfo group, a hydroxy group, an acetylamino group, a halogen atom, a cyano group, a nitro group, a sulfamoyl group, (C1-C8 ) Represents an alkyl group or (C1-C8) alkoxy group, R 3 represents a (C1-C8) alkyl group or (C1-C8) alkoxy group, R 4 represents a hydrogen atom, (C1-C8) alkyl group, (C2-C8) represents an alkenyl group, an aryl group, or a heteroaryl group. R 2 and R 3 may be bonded to each other to form a cyclic structure. Further, R 3 may be bonded to each other to form a dimer. ]
  2.  前記式(1)において、R及びRがいずれも水素原子である請求項1に記載の化合物。 The compound according to claim 1, wherein in the formula (1), R 1 and R 2 are both hydrogen atoms.
  3.  前記式(1)において、Rがメチル基である請求項1又は2に記載の化合物。 The compound according to claim 1 or 2, wherein in the formula (1), R 4 is a methyl group.
  4.  請求項1~3のいずれか一項に記載の化合物を含有する光硬化性組成物。 A photocurable composition containing the compound according to any one of claims 1 to 3.
  5.  硬化性化合物を含有する請求項4に記載の光硬化性組成物。 The photocurable composition according to claim 4, comprising a curable compound.
  6.  前記硬化性化合物が(メタ)アクリル化合物である請求項5に記載の光硬化性組成物。 The photocurable composition according to claim 5, wherein the curable compound is a (meth) acrylic compound.
  7.  前記硬化性化合物が、(メタ)アクリル化合物とエポキシ化合物との混合物である請求項5に記載の光硬化性組成物。 The photocurable composition according to claim 5, wherein the curable compound is a mixture of a (meth) acrylic compound and an epoxy compound.
  8.  有機フィラーを含有する請求項4~7のいずれか一項に記載の光硬化性組成物。 The photocurable composition according to any one of claims 4 to 7, comprising an organic filler.
  9.  前記有機フィラーが、ウレタン微粒子、アクリル微粒子、スチレン微粒子、スチレンオレフィン微粒子、及びシリコーン微粒子からなる群より選択される少なくとも1種の有機フィラーである請求項8に記載の光硬化性組成物。 The photocurable composition according to claim 8, wherein the organic filler is at least one organic filler selected from the group consisting of urethane fine particles, acrylic fine particles, styrene fine particles, styrene olefin fine particles, and silicone fine particles.
  10.  無機フィラーを含有する請求項4~9のいずれか一項に記載の光硬化性組成物。 The photocurable composition according to any one of claims 4 to 9, which contains an inorganic filler.
  11.  シランカップリング剤を含有する請求項4~10のいずれか一項に記載の光硬化性組成物。 The photocurable composition according to any one of claims 4 to 10, comprising a silane coupling agent.
  12.  熱硬化剤を含有する請求項4~11のいずれか一項に記載の光硬化性組成物。 The photocurable composition according to any one of claims 4 to 11, comprising a thermosetting agent.
  13.  前記熱硬化剤が有機酸ヒドラジド化合物である請求項12に記載の光硬化性組成物。 The photocurable composition according to claim 12, wherein the thermosetting agent is an organic acid hydrazide compound.
PCT/JP2018/020225 2017-06-06 2018-05-25 Compound and photocurable composition using same WO2018225543A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019523455A JPWO2018225543A1 (en) 2017-06-06 2018-05-25 Compound and photocurable composition using the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017111972 2017-06-06
JP2017-111972 2017-06-06

Publications (1)

Publication Number Publication Date
WO2018225543A1 true WO2018225543A1 (en) 2018-12-13

Family

ID=64566565

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/020225 WO2018225543A1 (en) 2017-06-06 2018-05-25 Compound and photocurable composition using same

Country Status (3)

Country Link
JP (1) JPWO2018225543A1 (en)
TW (1) TW201902886A (en)
WO (1) WO2018225543A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021246363A1 (en) * 2020-06-02 2021-12-09 積水化学工業株式会社 Sealing agent for liquid crystal display elements, vertical conduction material, and liquid crystal display element
WO2024199395A1 (en) * 2023-03-31 2024-10-03 常州强力先端电子材料有限公司 Oxime ester photoinitiator, photocurable resin composition and use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005263987A (en) * 2004-03-18 2005-09-29 Mitsui Chemicals Inc Photocurable resin composition and liquid crystal sealing agent composition comprising the same
JP2007100074A (en) * 2005-09-06 2007-04-19 Taiyo Ink Mfg Ltd Resin composition and cured product thereof and printed wiring board obtained by using the same
JP2007273768A (en) * 2006-03-31 2007-10-18 Nippon Steel Chem Co Ltd Adhesive sheet and its using method
JP2008179797A (en) * 2006-12-28 2008-08-07 Jsr Corp Sealing agent for liquid crystal display element, and liquid crystal display element
JP2008233421A (en) * 2007-03-19 2008-10-02 Fujifilm Corp Photosensitive composition, photosensitive film, permanent pattern forming method and printed circuit board
WO2009054276A1 (en) * 2007-10-25 2009-04-30 Sekisui Chemical Co., Ltd. Sealing material for liquid crystal dispensing method, transfer material and liquid crystal displays
JP2010204174A (en) * 2009-02-27 2010-09-16 Fujifilm Corp Photosensitive laminate and photosensitive film, and production method of printed board

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005263987A (en) * 2004-03-18 2005-09-29 Mitsui Chemicals Inc Photocurable resin composition and liquid crystal sealing agent composition comprising the same
JP2007100074A (en) * 2005-09-06 2007-04-19 Taiyo Ink Mfg Ltd Resin composition and cured product thereof and printed wiring board obtained by using the same
JP2007273768A (en) * 2006-03-31 2007-10-18 Nippon Steel Chem Co Ltd Adhesive sheet and its using method
JP2008179797A (en) * 2006-12-28 2008-08-07 Jsr Corp Sealing agent for liquid crystal display element, and liquid crystal display element
JP2008233421A (en) * 2007-03-19 2008-10-02 Fujifilm Corp Photosensitive composition, photosensitive film, permanent pattern forming method and printed circuit board
WO2009054276A1 (en) * 2007-10-25 2009-04-30 Sekisui Chemical Co., Ltd. Sealing material for liquid crystal dispensing method, transfer material and liquid crystal displays
JP2010204174A (en) * 2009-02-27 2010-09-16 Fujifilm Corp Photosensitive laminate and photosensitive film, and production method of printed board

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021246363A1 (en) * 2020-06-02 2021-12-09 積水化学工業株式会社 Sealing agent for liquid crystal display elements, vertical conduction material, and liquid crystal display element
JP6997359B1 (en) * 2020-06-02 2022-01-17 積水化学工業株式会社 Sealing agent for liquid crystal display element, vertical conduction material, and liquid crystal display element
WO2024199395A1 (en) * 2023-03-31 2024-10-03 常州强力先端电子材料有限公司 Oxime ester photoinitiator, photocurable resin composition and use

Also Published As

Publication number Publication date
JPWO2018225543A1 (en) 2020-04-09
TW201902886A (en) 2019-01-16

Similar Documents

Publication Publication Date Title
JP6478313B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP2018104662A (en) Photocurable resin composition and electronic component sealant
JP6238850B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP2016109997A (en) Liquid crystal sealant and liquid crystal cells using the same
JP2016024243A (en) Liquid crystal sealant and liquid crystal cell using the same
JP6535002B2 (en) Liquid crystal sealing agent and liquid crystal display cell using the same
WO2018225543A1 (en) Compound and photocurable composition using same
JP6744168B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP6338745B1 (en) Photocurable resin composition and sealant for electronic parts
JP6486571B1 (en) Adhesive for electronic parts
JP7266484B2 (en) Sealant for electronic parts
JP6249946B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP2017198726A (en) Sealant for liquid crystal optical element and liquid crystal optical element using the same
JP2017027043A (en) Liquid crystal sealant and liquid crystal display cell using the same
JP6710125B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP6426050B2 (en) Liquid crystal sealing agent and liquid crystal display cell using the same
JP2016038509A (en) Liquid crystal sealing agent and liquid crystal display cell having the same
JP2018105989A (en) Sealing agent for display device and display device using the same
JP6478788B2 (en) Liquid crystal sealing agent and liquid crystal display cell using the same
JP2024115813A (en) Liquid crystal sealant for liquid crystal dropping method and liquid crystal display cell using same
JP6341603B2 (en) Liquid crystal sealant and liquid crystal display cell using the same
JP2018063274A (en) Liquid crystal sealant and liquid crystal display cell using the same
JP2015203834A (en) Liquid crystal sealant for liquid crystal dropping method and liquid crystal cell using the same
JP2018040947A (en) Liquid crystal sealing agent and liquid crystal display cell using the same
JP2017203906A (en) Liquid crystal sealant and liquid crystal display cell using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18814365

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019523455

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18814365

Country of ref document: EP

Kind code of ref document: A1